Introduction {#s1}
============

NMDA- and AMPA-type glutamate receptors (NMDARs/AMPARs) are the major excitatory synaptic receptors in brain. They are held at post-synaptic densities (PSDs) by scaffold proteins aligning the receptors with the presynaptic glutamate release sites. Changes in synaptic strength, such as long-term potentiation (LTP), long-term depression (LTD) ([@bib32]), and homeostatic plasticity ([@bib41]), largely reflect the number of functional synaptic AMPARs. AMPAR internalization and recycling regulates AMPAR levels at synapses. Other processes, including diffusion of extrasynaptic AMPARs outside PSDs, association and dissociation of AMPARs with PSDs, and the number of 'slots' that AMPAR can occupy in PSDs ([@bib32]; [@bib14]; [@bib29]; [@bib43]; [@bib15]), also contribute to setting AMPAR levels at PSDs ([@bib38]).

During synaptic stimulation, 'constitutive' AMPAR recycling is increased several fold to become 'activity-dependent' AMPAR recycling ([@bib14]). AMPARs undergo endocytosis through clathrin-coated pits during activity-dependent recycling ([@bib7]; [@bib31]) and before exocytosis, traffic through the recycling endosomes (REs) identified by co-localization with transferrin receptors (TfRs) ([@bib14]) and Rab11 ([@bib39]). During LTP, REs move from the dendritic shaft into synaptic spines ([@bib40]) from which regulated exocytosis of AMPARs appears to occur. It is uncertain whether AMPARs are exocytosed outside of the spines and traffic to PSDs via lateral diffusion ([@bib4]; [@bib52]; [@bib48]; [@bib33]) or are exocytosed at specific sites near PSDs ([@bib34]). A minimal model of AMPAR constitutive and activity-dependent recycling has emerged from these and other studies. First, a single recycling pathway is assumed that starts at clathrin-coated pits ([@bib5]), moves through REs, and ends with exocytosis back at the plasma membrane. Second, it is assumed that AMPAR recycling occurs locally, that is, AMPAR endocytosis and exocytosis occur at sites within the same synaptic domain. The model predicts that during LTD-AMPAR levels in recycling, endosomes and/or lysosomes at PSDs increase because endocytosis increases without increasing exocytosis from REs ([@bib14]; [@bib16]). During LTP, endocytosis is unchanged and AMPAR levels at PSDs are predicted to increase because of their exocytosis from REs causing decreased levels of AMPARs in REs ([@bib40]; [@bib22]).

Many factors specifically affect AMPAR activity-dependent recycling without affecting constitutive recycling \[e.g., AP2 ([@bib27]), Brag2 ([@bib46])\], and vice versa \[e.g., NSF ([@bib27]), PIP3 ([@bib2])\]. These studies suggest that AMPAR activity-dependent recycling is uncoupled from constitutive recycling and that separate processes underlie the two types of AMPAR recycling. Transmembrane AMPA receptor regulatory proteins (TARPs), such as stargazin, interact with recycling AMPARs at synapses ([@bib50]; [@bib36]). TARPs interact with neuronal isoform of PDZ-protein interacting specifically with TC10 (nPIST) ([@bib11]), suggesting that the Rho small G protein, TC10, might be a regulator of AMPAR recycling. Here, we describe how TC10 knockdown and TC10 functional mutants reduce AMPAR surface levels and synaptic currents by altering AMPAR recycling. TC10 mutants do not alter the increases in AMPAR surface levels that occur during LTP and only partially alter decreases in AMPAR surface levels and synaptic currents that occur during LTD. Overall, our findings indicate that TC10 mutants have differential effects on constitutive and activity-dependent AMPAR recycling because AMPARs traffic through different endocytosis pathways, and activity-dependent events alter the endocytosis pathway taken by AMPARs. Furthermore, our findings of increased AMPAR endocytosis with LTP are inconsistent with the assumption that AMPAR recycling occurs locally at synapses. Instead, AMPARs added to LTP-stimulated synapses may be trafficked into these synapses from outside the local synaptic pool.

Results {#s2}
=======

Disrupting TC10 expression or function reduced the number of AMPARs at the cell surface {#s2-1}
---------------------------------------------------------------------------------------

We first examined whether the small GTPase, TC10, had a role in AMPAR trafficking by knocking down TC10 expression ([Figure 1](#fig1){ref-type="fig"}). Knockdown was achieved using a short hairpin RNA construct (shRNA) that expressed a GFP reporter to identify neurons with the shRNA. Using real-time PCR, we observed that endogenous TC10 mRNA was reduced by 90% in cortical neurons ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Neurons were co-transfected with AMPAR subunits, GluA1, with a fluorescent mCherry tag at the extracellular N-terminus (mCherry-GluA1) to simultaneously monitor GluA1 surface fluorescence and total GluA1 mCherry fluorescence. We found that the ratio of cell surface to total mCherry-GluA1 was similar from neuron to neuron (SEM = 14%). With the TC10 knockdown, the surface/total mCherry-GluA1 ratio for neurons was significantly reduced by 79% ([Figure 1A,D](#fig1){ref-type="fig"}) compared to control neurons that expressed GFP without the shRNA.10.7554/eLife.06878.003Figure 1.Disrupting TC10 level or function reduced AMPARs on the cell surface.(**A**) Representative somata of cultured rat hippocampal neurons (E18) expressing mCherry-tagged GluA1 subunits, free Venus (Control), shTC10RNA or Venus-tagged TC10WT, TC10DN or TC10CA. Intact, live neurons (DIV18) were stained with anti-RFP antibody to visualize surface AMPA-type glutamate receptors (AMPARs) and then fixed and processed. Images of the whole neuron for each of the shown somata are displayed in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}. (Scale bar = 10 μm). (**B**) Representative dendrites of neurons expressing mCherry-GluA1 without TC10 or with TC10WT, TC10DN, or TC10CA. Arrows indicate dendrites expressing TC10 mutants (TC10DN or CA) with weak surface expression of GluA1; arrowheads mark dendrites expressing mCherry-GluA1 without TC10 mutant expression and normal GluA1 surface expression level. (Scale bar = 5 μm). (**C**) Representative dendrites of intact neurons expressing either free Venus (Control), TC10WT, TC10DN, or TC10CA and labeled with an N-terminal, anti-GluA1 mAb to visualize endogenous, surface GluA1 receptors. (Scale bar = 5 μm). (**D**) Quantification of the surface/total ratio of mCherry-GluA1 at the somata of transfected cells in (**A**). Data are shown as ± SEM; control cells (YFP) 100% ± 14%, n = 32; TC10WT cells 118% ± 22%, n = 17; TC10DN cells 53% ± 9%, n = 23; TC10CA cells 47% ± 9%, n = 14; and shTC10 cells 21% ± 7%, n = 10. (\*\*p \< 0.03 relative to TC10WT). (**E**) Quantification of the surface/total ratio of mCherry-GluA1 in dendrites of transfected cells in (**B**). Data are shown as ± SEM; control cells (YFP) 100% ± 12%, n = 23; TC10WT cells 133% ± 11%%, n = 23; TC10DN cells 53% ± 5%, n = 23; and TC10CA cells 54% ± 15%, n = 8. (\*p \< 0.03 relative to YFP;\*\*p \< 0.02 relative to TC10WT). (**F**) Quantification of endogenous surface GluA1 on dendrites in (**C**). Data are shown as mean ± SEM; control cells (YFP) 100% ± 11%; TC10WT cells 130% ± 17%; TC10DN cells 59% ± 8%; and TC10CA cells 62% ± 10% (n = 7--10 cells per group; \*\*p \< 0.003 relative to TC10WT). (**G**) Representative whole-cell patch-clamp paired recordings showing the evoked presynaptic action potential (top) and the post-synaptic AMPAR-mediated current response (below). (**H**) Average AMPAR-mediated EPSC amplitudes of untransfected neurons (control) 365.2 ± 67 pA, n = 16 and neurons transfected with TC10WT 180.3 ± 36 pA, n = 8; TC10DN 144.5 ± 42 pA, n = 14; or TC10CA 139.2 ± 24 pA, n = 11. (\*p \< 0.04 relative to control;\*\*p \< 0.02 relative to control).**DOI:** [http://dx.doi.org/10.7554/eLife.06878.003](10.7554/eLife.06878.003)10.7554/eLife.06878.004Figure 1---figure supplement 1.TC10 RNAi (shRNA) knocked down endogenous TC10 expression in neurons.Cortical neurons were infected with lentivirus encoding FUGW empty vector or TC10 short hairpin RNA construct (shRNA) on DIV7 and lysed for real-time PCR on DIV11. shTC10 specifically knocked down TC10 mRNA level by 90%, but not the expression of Cdc42 and Rab11.**DOI:** [http://dx.doi.org/10.7554/eLife.06878.004](10.7554/eLife.06878.004)10.7554/eLife.06878.005Figure 1---figure supplement 2.Low-magnification images of cultured rat hippocampal neurons (E18) corresponding to the somata shown in [Figure 1A](#fig1){ref-type="fig"}.Neurons express mCherry-tagged GluA1 subunits and either free Venus (Control), TC10WT, TC10DN, or TC10CA. Intact, live neurons (DIV18) were stained with anti-RFP antibody to visualize surface AMPARs and then fixed and imaged. (Scale bar = 10 um).**DOI:** [http://dx.doi.org/10.7554/eLife.06878.005](10.7554/eLife.06878.005)10.7554/eLife.06878.006Figure 1---figure supplement 3.TC10 mutants do not change synaptic density.The density of synapsin (SYN) puncta (number of puncta/um) remained unchanged when TC10WT or TC10DN/CA mutants were expressed (n.s. = not significant).**DOI:** [http://dx.doi.org/10.7554/eLife.06878.006](10.7554/eLife.06878.006)10.7554/eLife.06878.007Figure 1---figure supplement 4.TC10 mutants do not change the expression level of GluA1.(**A**) Cortical neurons were infected with lentivirus encoding Venus-TC10WT or TC10DN/CA mutants on DIV1 and assayed for GluA1 expression with Western blot on DIV18. The expression of GluA1 remained unchanged. (**B**) Quantification of GluA1 expression level in (**A**), normalized to tubulin (n=3 experiments).**DOI:** [http://dx.doi.org/10.7554/eLife.06878.007](10.7554/eLife.06878.007)10.7554/eLife.06878.008Figure 1---figure supplement 5.A comparison of somatic ER and the distribution of exogenous mCherry-GluA1 subunits and endogenous GluA1 subunits.Cultured neurons expressing mCherry-tagged GluA1 (top panel) were stained with an antibody against the endoplasmic reticulum (ER) marker protein, protein disulfide isomerase, and compared against endogenous GluA1 in untransfected cells (bottom panel). Both exogenous and endogenous GluA1 exhibited similar distributions in somatic ER. (Scale bar = 10 um).**DOI:** [http://dx.doi.org/10.7554/eLife.06878.008](10.7554/eLife.06878.008)10.7554/eLife.06878.009Figure 1---figure supplement 6.The effects of TC10 mutants on AMPARs in the somatic Golgi and in dendritic shafts.(**A**) Cultured hippocampal neurons expressing mCherry-GluA1 with Venus, TC10WT, TC10DN, or TC10CA were fixed and stained for the Golgi marker, GM130 on DIV18. (Scale bar = 10 um). (**B**) Quantification of the intensity of mCherry-GluA1 co-localizing with GM130 in the somata. Expression of TC10 WT or mutants did not change its distribution: Control cells (normalized) 100% ± 2%, n=11; TC10WT cells 103% ± 3%, n=6; TC10DN cells 109% ± 10%, n=19; TC10CA cells 104% ± 3%, n=15. (**C**) Line profile of mCherry-GluA1 intensity along the dendrite when co-expressed with Venus or TC10DN. TC10DN expression results in mCherry-GluA1 accumulation in the dendritic shafts and not in the somata. (Scale bar = 5 um, n=4).**DOI:** [http://dx.doi.org/10.7554/eLife.06878.009](10.7554/eLife.06878.009)

The surface levels of GluA1-containing AMPARs at somata were also reduced when we expressed TC10 mutants in the neurons. The T31N mutation or the 'dominant-negative' mutant (TC10DN) keeps TC10 in its inactive, GDP-bound state. The Q75L mutation or the 'constitutively active' mutant (TC10CA) is kept in its GTP-bound state ([@bib36]). Expression of wild-type TC10 (TC10WT) did not significantly alter surface levels at somata assayed by mCherry-GluA1 transfection, whereas TC10DN and TC10CA mutants reduced GluA1-containing AMPAR surface levels by ∼50% ([Figure 1A,B](#fig1){ref-type="fig"}; statistical details in the legend; images of the corresponding whole neurons are displayed in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). While TC10 knockdown with shRNA did not alter somata morphology, dendritic morphology was altered and synapse numbers reduced (not shown). In contrast, TC10DN, TC10CA mutants, and TC10WT did not alter dendrite morphology (not shown) or synapse number ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). In dendrites, GluA1 surface levels were again reduced ∼50% by TC10DN and TC10CA and a small but significant increase of GluA1 surface levels (33% ± 10%) was observed with TC10WT expression ([Figure 1A](#fig1){ref-type="fig"}). We obtained similar results in dendrites with TC10WT, TC10DN, and TC10CA, when a GluA1-specific antibody that recognizes an extracellular epitope was used to quantify the endogenous surface AMPAR levels ([Figure 1F](#fig1){ref-type="fig"}).

We also performed paired whole cell recordings from synaptically coupled cultured hippocampal neurons to assay levels of functional AMPARs at the synapses. TC10DN and TC10CA reduced the synaptic AMPAR EPSC amplitudes by ∼60% ([Figure 1G,H](#fig1){ref-type="fig"}). Thus, the number of functional AMPARs at synapses was reduced to approximately the same extent as the total number of AMPARs on the cell surface as measured by immunostaining. Our findings with immunofluorescence and electrophysiology that expression of TC10DN and TC10CA in neurons caused the same effects on AMPAR levels in neurons are consistent with previous studies characterizing the role of TC10 in the secretory pathway. Assaying depolarization-induced secretion of neuropeptide Y (NPY) in PC12 cells, both TC10DN and TC10CA reduced secretion in the range of 40--60% ([@bib24]) similar to our findings with AMPARs ([Figure 1](#fig1){ref-type="fig"}). Using a TC10 FRET sensor construct to assay whether TC10 is in the GTP-TC10 or GDP-TC10 state, they concluded that the TC10 GTPase hydrolysis cycle is required for NPY secretion. TC10DN and TC10CA both reduced secretion by blocking the GTP hydrolysis cycle at different steps. Similar results were obtained assaying nerve growth factor-induced neurite outgrowth in PC12 cells ([@bib18]). Both papers suggested that during exocytosis TC10CA allowed cargo to load into transport vesicles to be delivered to target membranes. TC10CA blocked exocytosis by preventing the GTP-TC10 to GDP-TC10 transition required for transport vesicle docking and/or fusion. In contrast, the results suggest that TC10DN blocked the GDP-TC10 to GTP-TC10 transition, which blocked a different step, cargo loading onto vesicles thus preventing vesicle delivery to target membranes.

Unexpectedly, in the paired whole-cell recordings from synaptically coupled cultured hippocampal neurons, TC10WT reduced synaptic currents by 51% ([Figure 1E,F](#fig1){ref-type="fig"}) even though TC10WT increased cell-surface AMPARs by 33% ([Figure 1B,C](#fig1){ref-type="fig"}). This differential effect of TC10WT suggests that TC10 function somehow distinguishes between AMPAR trafficking to and/or from synaptic sites compared to other sites on the cell surface of dendrites.

TC10 regulates AMPAR trafficking through an Arf6-containing endocytosis pathway in dendrites {#s2-2}
--------------------------------------------------------------------------------------------

To explore how perturbing TC10 function reduced AMPAR surface levels, we examined whether TC10 mutants altered endogenous GluA1 subunit levels. Lentiviral infection of ∼90% of the cultured neurons with TC10WT or the TC10 mutants did not alter endogenous GluA1 subunit levels, indicating that TC10 mutants do not alter AMPAR subunit synthesis or degradation ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). Nor did the TC10 mutant expression appear to alter AMPAR trafficking through the secretory pathway in the soma ([Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}). Previously, we had found that AMPAR loss in dendrites correlated with AMPAR accumulation in the Golgi, which blocked AMPAR transport from somata to dendrites of cultured neurons ([@bib23]). Consistent with this possibility, TC10WT, TC10DN, and TC10CA all strongly co-localized with the Golgi marker GM130 in somata ([Figure 1---figure supplement 6A](#fig1s6){ref-type="fig"}). However, little mCherry-GluA1 was found in the Golgi, and most GluA1 subunits co-localized with endoplasmic reticulum (ER) markers ([Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}), as previously observed for newly synthesized AMPAR subunits ([@bib21]). We observed a similar distribution for the native GluA1 subunits in the ER ([Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}) indicating that heterologous express of mCherry-GluA1 did not greatly increase levels of GluA1 in the ER. The small amount of mCherry-GluA1 that co-localized with the Golgi marker did not significantly change with TC10DN and TC10CA expression compared to that of TC10WT ([Figure 1---figure supplement 6A,B](#fig1s6){ref-type="fig"}). In fact, when TC10 mutants were expressed, there was a significant increase in mCherry-GluA1 levels in the shafts of dendrites ([Figure 1---figure supplement 6C](#fig1s6){ref-type="fig"}), suggesting that the TC10 mutants cause an accumulation of AMPAR intracellular levels in the dendritic shafts, but not in the somata, that results in the decreases in surface levels.

We next examined whether the TC10 mutants caused AMPARs to accumulate during their recycling in dendritic shafts. It is well established that AMPARs enter REs in dendritic shafts after synaptic stimulation with AMPA or NMDA ([@bib32]; [@bib37]). To test for accumulation of AMPARs in REs, we assayed whether TC10 mutants increased endogenous AMPAR co-localization with TfRs, which largely exist in REs in dendritic shafts where they co-localize with GluA1-containing AMPARs ([@bib7]; [@bib14]). Surprisingly, there was little co-localization, (4--6%), between endogenous GluA1 and TfR in dendrites under these conditions. The percentage of co-localization did not change for non-transfected neurons or for neurons expressing Venus-tagged TC10WT, TC10DN, or TC10CA ([Figure 2A,B](#fig2){ref-type="fig"}). TC10WT, TC10DN, or TC10CA expression also did not alter the distribution of TfRs in the dendrites and did not significantly affect the recycling of TfRs (data not shown). To confirm the validity of TfRs as a recycling endosome marker, we tested another recycling endosome protein, Rab11, and found significant co-localization between mCherry-tagged Rab11 and TfRs confirming that TfRs are largely in REs in dendrites ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).10.7554/eLife.06878.010Figure 2.TC10 regulates AMPAR trafficking through an Arf6-containing endocytosis pathway in dendrites.(**A**) Effects of TC10 constructs on the co-localization between endogenous GluA1 subunits and transferrin receptors (TfRs). Cultured neurons were transfected with Venus-tagged TC10WT or TC10DN/CA mutants and permeabilized cells stained for total GluA1 and TfR (Tf-Alexa 647). GluA1 showed little co-localization with Tf-labeled endosomes in dendrites. (Scale bar = 5 μm). (**B**) Quantification of GluA1 and TfR co-localization. Images in A were analyzed to measure the percent of GluA1 puncta co-localizing with TfR puncta. Expression of TC10 constructs did not alter the degree of co-localization. Data are shown as mean ± SEM; control cells 4.6% ± 0.3%; TC10WT cells 4.9% ± 0.8%; TC10DN cells 4.2% ± 0.8%; TC10CA cells 5.6% ± 1%, n = 5 for all groups. (**C**) Effects of TC10 constructs on the co-localization between GluA1 subunits and Arf6. Neurons were transfected with Arf6-HA and Venus-TC10WT or TC10DN/CA mutants. Cells were permeabilized and stained for Arf6-HA (Rb anti-HA) and total GluA1 (anti-GluA1 mAb). (Scale bar = 5 μm). (**D**) Quantification of the overlap between GluA1 and Arf6. Images in C were analyzed to measure the Pearson\'s correlation coefficients (R~r~) of GluA1 co-localization with Arf6. Data are shown as mean ± SEM; TC10WT 0.46 ± 0.04; TC10DN 0.66 ± 0.04; TC10CA 0.31 ± 0.04 (n = 7-10 cells per group; \*p \< 0.02 relative to TC10WT; \*\*p \< 0.05 relative to TC10WT). (**E**) Effects of TC10 constructs on GluA1 puncta density (number of puncta per 10 μm) in dendrites of neurons expressing Venus-TC10WT or TC10DN/CA mutants. Data are shown as mean ± SEM; TC10WT 6.9 ± 0.4; TC10DN 5.6 ± 0.7; TC10CA 41.7 ± 4.8 (n = 5 fields per group; \*p \< 0.0002 relative to TC10WT). Inset, histogram showing the distribution of small (diameter \<200 nm) and large (diameter 200--1200 nm) GluA1 puncta (n = ∼100 puncta per group). (**F**) Quantification of the overlap (Pearson\'s correlation coefficients, R~r~) between TC10 and Arf6 in (**C**). Data are shown as mean ± SEM; TC10WT 0.77 ± 0.03; TC10DN 0.60 ± 0.02; TC10CA 0.84 ± 0.02 (n = 7--10 cells per group; \*p \< 0.0004 relative to TC10WT).**DOI:** [http://dx.doi.org/10.7554/eLife.06878.010](10.7554/eLife.06878.010)10.7554/eLife.06878.011Figure 2---figure supplement 1.Co-distribution of TfR staining and mCherry-Rab11.Hippocampal cultures were stained for TfR and Rab11 on DIV18. The two markers showed extensive overlap. (Scale bar = 5 um).**DOI:** [http://dx.doi.org/10.7554/eLife.06878.011](10.7554/eLife.06878.011)

Since few GluA1-containing AMPARs accumulated in TfR-labeled REs, it is possible that AMPAR recycling occurs via a different endocyctosis pathway not taken by TfRs. Several other endocytosis pathways exist ([@bib12]). In particular, one endocyctosis pathway that utilizes the small GTPase, Arf6, occurs in dendrites ([@bib20]; [@bib26]) and may be involved in AMPAR endocytosis ([@bib46]). In contrast to the ∼5% co-localization observed between GluA1 and TfR puncta, we observed a significantly higher degree of overlap (Pearson\'s correlation coefficient, PCC = 0.46) between endogenous GluA1 subunits and transfected HA-Arf6 ([Figure 2C,D](#fig2){ref-type="fig"}), an established marker of endosomes in the Arf6, clathrin-independent pathway ([@bib13]). Importantly, there was a high degree of co-localization between TC10WT and HA-Arf6 (PCC = 0.77), indicating that TC10 is largely found in Arf6 endosomes in dendrites ([Figure 2E](#fig2){ref-type="fig"}).

Consistent with TC10 having a role in AMPAR recycling through Arf6 endosomes, the TC10 mutants caused significant changes in the distribution of AMPAR intracellular puncta that co-localized with Arf6 ([Figure 2C,D](#fig2){ref-type="fig"}). TC10DN significantly increased GluA1 co-localization with Arf6, changing from a PCC of 0.46 to 0.66 ([Figure 2C,D](#fig2){ref-type="fig"}). Increases in AMPARs co-localizing with Arf6 appeared to be at subdomains within Arf6 endosomes ([Figure 2C](#fig2){ref-type="fig"}), consistent with TC10CA blocking AMPAR exit, and their accumulation in Arf6-endosomes. The TC10CA mutant had the opposite effect. TC10CA caused GluA1 co-localization with Arf6 to significantly decrease from a PCC of 0.46 to 0.31, consistent with increased AMPAR exit from Arf6 endosomes ([Figure 2C,D](#fig2){ref-type="fig"}). Because TC10CA caused a ∼50% decrease in surface AMPAR, similar to the effects of TC10DN ([Figure 1B,C and F](#fig1){ref-type="fig"}), increases in AMPARs exiting from Arf6 endosomes were not inserted into the cell surface. Expression of TC10CA changed the size and number of the GluA1-containing puncta in dendritic shafts. GluA1-containing puncta were much more numerous compared to TC10WT, with an increased number of smaller puncta and a loss of most of the larger puncta in dendrites ([Figure 2E](#fig2){ref-type="fig"}). This result suggests that the AMPARs exiting from Arf6 endosomes remained in smaller transport vesicles because TC10CA blocked their exocytosis at the plasma membrane. These interpretations of the effects of the TC10DN and TC10CA mutants are supported by the conclusions of previous studies of the effects of the TC10 mutants on the distribution of different cargo during secretion ([@bib24]; [@bib18]); specifically that TC10DN blocked the GDP-TC10 to GTP-TC10 transition and cargo loading onto the transport vesicle, while TC10CA blocked the GTP-TC10 to GDP-TC10 transition and the transport vesicle exocytosis.

Constitutive AMPAR endocytosis is independent of dynamin {#s2-3}
--------------------------------------------------------

The clathrin-dependent endocytosis pathway taken by TfRs requires dynamin function, while Arf6-dependent clathrin-independent endocytosis is independent of dynamin function ([@bib12]). As another test of the AMPAR endocytosis pathway, we used the reagent, dynasore, to block dynamin activity in neurons and assayed TfR and AMPAR endocytosis. In these experiments, we performed two different sets of assays to quantitatively measure how dynasore affected AMPAR and TfR internalization. In the first assay, mCherry-tagged GluA1 was expressed as in [Figure 1](#fig1){ref-type="fig"}, and an 'antibody feeding' assay was used to label only the internalized mCherry-tagged, GluA1 AMPARs, and TfRs ([Figure 3A,B](#fig3){ref-type="fig"}). After dynasore treatment, we compared the distribution of internalized mCherry-GluA1 subunits to that of TfRs surface labeled with Alexa Fluor 647-conjugated transferrin (Tf-Alexa 647; [Figure 3A](#fig3){ref-type="fig"}). Consistent with a block of its endocytosis, dynasore treatment appeared to cause TfRs to buildup at the plasma membrane ([Figure 3A](#fig3){ref-type="fig"}). Tf-Alexa 647 uptake was inhibited by 70% ± 18% in the presence of dynasore ([Figure 3B,C](#fig3){ref-type="fig"}). However, dynasore treatment did not significantly alter the levels ([Figure 3C](#fig3){ref-type="fig"}) or distribution ([Figure 3A](#fig3){ref-type="fig"}) of internalized mCherry-GluA1 subunits.10.7554/eLife.06878.012Figure 3.AMPARs undergo dynamin-independent endocytosis.(**A**) mCherry-GluA1 and TfR internalization and block of dynamin function. Hippocampal neurons were transfected with mCherry-GluA1, and 1 day post-transfection, treated with 1% DMSO (control group) or 80 μM dynasore (to block dynamin function) for 30 min at 37°C. Neurons were then incubated with anti-RFP antibodies and Tf-Alexa 647 at 37°C for 40 min, acid washed to remove surface antibodies/dye, fixed, permeabilized, and imaged. With sham treatment (control), surface-labeled GluA1 and TfR were both internalized in the dendritic shaft (first row). Dynasore treatment had no effect on GluA1 internalization, but blocked TfR endocytosis (Tf-Alexa 647 labeling confined to surface and not present intracellularly, second row). (**B**) Intensity plots of internalized TfR (Tf-Alexa 647) with and without (sham) dynasore treatment as in (**A**). Dynasore greatly inhibited TfR internalization. (**C**) Quantification of GluA1 and Tf-Alexa647 internalization and block of dynamin function. Data are shown as mean ± SEM; GluA1 endocytosis, sham 100% ± 16%; dynasore 112% ± 12%. For Tf-Alexa647 endocytosis, sham 100% ± 23%; dynasore 30% ± 18%, (n = 5 for all groups; \*\*\*p \< 0.001). (**D**) Endogenous GluA1 and TfR internalization and block of dynamin function. As an alternative approach to measure GluA1 and TfR Internalization, cortical neurons were sham treated (with DMSO) or with dynasore as in (**A**). After, surface proteins were labeled with Sulfo-NHS-SS-biotin and cultured for 40 min at 37°C to allow for endocytosis. Biotin on proteins remaining on the cell surface was removed by glutathione treatment and cells solubilized. Internalized proteins were pulled down with streptavidin beads and analyzed by Western blotting. Displayed are GluA1, TrR, and actin bands (loading control) from whole cell lysates to estimate inputs for sham- or dynasore-treated neurons (left) and GluA1 and TfR bands from the streptavidin pull-downs to estimate internalized receptors for sham- or dynasore-treated neurons (right). (**E**) Quantification of GluA1 and TfR internalization and block of dynamin function. The levels of GluA1 endocytosis were reduced to 90% ± 9% vs sham treated by dynasore treatment. The levels of TfR endocytosis were reduced to 61% ± 6% (n = 3 experiments; \*\*\*p \< 0.01) vs sham treated by dynasore treatment. Total protein levels (inputs) for GluA1 and TfR were not affected by dynasore treatment.**DOI:** [http://dx.doi.org/10.7554/eLife.06878.012](10.7554/eLife.06878.012)

In the second assay, endogenous AMPAR internalization was assayed by biotinylating cell-surface proteins with a cleavable biotinylation cross-linking reagent and treating intact neurons with glutathione, a membrane impermeable reagent after internalization. Dynasore treatment reduced the levels of internalized TfR by 61% ± 6% ([Figure 3D,E](#fig3){ref-type="fig"}), consistent with endocytosis predominantly through clathrin-dependent endocytosis pathway. In contrast, dynasore treatment reduced internalized GluA1 subunits by only 10% ± 9% ([Figure 3D,E](#fig3){ref-type="fig"}), consistent with endocytosis predominantly through a different endocytosis pathway. Based on these results together with previous data ([Figure 2](#fig2){ref-type="fig"}), we conclude that TC10 has a role in AMPAR recycling through an Arf6-dependent recycling pathway that is different from the TfR recycling pathway.

Changes in synaptic activity alter the recycling pathway taken by AMPARs {#s2-4}
------------------------------------------------------------------------

Evidence that AMPARs are in REs and clathrin-coated pits comes almost exclusively from studies examining AMPAR activity-dependent recycling. Our findings of AMPAR recycling via a TC10- and Arf6-dependent, dynamin-independent pathway occurred during constitutive AMPAR recycling. We, therefore, investigated whether the AMPAR endocytosis pathway changes under conditions where activity-dependent recycling occurs. First, we specifically tested how expressing TC10DN or TC10CA in neurons altered LTP and LTD. Chemically inducing LTP (cLTP) with glycine stimulation to activate synaptic NMDARs increased the AMPAR surface/total ratio by 39% ± 10% (p \< 0.1, n = 10, 14), while chemically inducing LTD (cLTD) with acute NMDA treatment, decreased the AMPAR surface/total ratio by 62% ± 3% ([Figure 4A,B](#fig4){ref-type="fig"}).10.7554/eLife.06878.013Figure 4.Synaptic activity alters the endocytosis pathway taken by AMPARs.(**A**) Effects of TC10 constructs on chemically inducing LTP (cLTP) and chemically inducing LTD (cLTD). Hippocampal neurons were transfected with mCherry-GluA1 plus Venus, TC10DN, or TC10CA. 1 day post-transfection, cells were stimulated with a mixture of the NMDA receptor agonist, glycine, and GABA~A~ receptors antagonists to induce long-term potentiation (LTP) chemically in hippocampal cultures. Then, surface exposed mCherry-GluA1 was stained live with anti-RFP antibody. In control cells, cLTP treatment caused a 39% increase in surface GluA1 (100% ± 9%, n = 10--139% ± 10%, n = 14). In cells expressing TC10DN and TC10CA, cLTP treatment also caused a 78% (37% ± 7%, n = 13--66% ± 9%, n = 12) and 54% (41% ± 4%, n = 21--63% ± 6%, n = 15) increase in surface GluA1, respectively. In parallel, transfected cells were treated with NMDA to chemically induce long-term depression (LTD) as well. Control cells showed a 62% decrease of surface GluA1 (100% ± 10%, n = 10--38% ± 3%, n = 11), while TC10DN and TC10CA expressing cells showed a 31% (67% ± 7%, n = 13--46% ± 3%, n = 10) and 55% (60% ± 5%, n = 5--27% ± 4.2%, n = 6) reduction, respectively. (**B**) Effects of TC10 constructs on cLTP and cLTD. Data in (**A**) replotted and normalized to respective sham values in order to compare the changes with cLTP and cLTD. (**C**) Effects of TC10 constructs on synaptically induced LTD. Left: AMPAR-EPSC amplitudes, expressed as a percentage of baseline AMPAR-EPSC amplitude (10 min), before and after the induction of LTD by electrical LFS for 5 min (gap). Right: Bar graph of the average AMPAR-EPSC amplitude depression measured 20 min after LFS. Control cells showed a 52.4% ± 0.5% reduction in AMPAR-EPSC amplitude after LTD induction; TC10DN and TC10CA showed a 27.5% ± 1.0% and 48.3% ± 1.0% reduction in AMPAR-EPSC amplitude, respectively. (**D**) mCherry-GluA1 internalization after cLTP. Neurons were sham or cLTP treated and imaged for internalized mCherry-GluA1 and either TfR or HA-Arf6. GluA1 internalization increased by 24% ± 5% when treated with cLTP (n = 6; \*\*p \< 0.01). (**E**) mCherry-GluA1 co-localization with TfR (left) and Arf6 (middle) after cLTP. Co-localization of internalized GluA1 with TfR increased with cLTP: sham-treated 21% ± 2%, n = 15; cLTP 56% ± 2%, n = 23 (\*\*\*p \< 0.0001). Co-localization of internalized GluA1 with Arf6 did not significantly change: sham treated 52% ± 2%, n = 12; cLTP 47% ± 3%, n = 5. Left panel displays the distribution of GluA1 co-localization with TfR, Arf6, or neither marker for sham treated and cLTP conditions.**DOI:** [http://dx.doi.org/10.7554/eLife.06878.013](10.7554/eLife.06878.013)10.7554/eLife.06878.014Figure 4---figure supplement 1.Synaptic activity alters the endocytosis pathway taken by AMPARs.Representative images for the quantification displayed in [Figure 4D, E](#fig4){ref-type="fig"}. Neurons were sham or cLTP treated and imaged for internalized mCherry-GluA1 and either TfR (**A**) or Arf6-HA (**B**). cLTP treatment caused an increase in the co-localization between internalized GluA1 and TfR, while co-localization with Arf6 didn\'t change (arrows indicate co-localizing puncta). (Scale bar = 5 um).**DOI:** [http://dx.doi.org/10.7554/eLife.06878.014](10.7554/eLife.06878.014)

Neurons expressing TC10DN or TC10CA showed increased AMPAR surface/total ratios with cLTP ([Figure 4A](#fig4){ref-type="fig"}). The percent increase in surface AMPARs was even larger than controls ([Figure 4B](#fig4){ref-type="fig"}). The larger percent increase may be explained by the fact that the cLTP-induced increases in surface AMPARs were about the same size as controls, while the levels of surface AMPARs were reduced by TC10 variants ([Figure 1](#fig1){ref-type="fig"}). The finding that TC10DN or TC10CA expression had no negative effect on cLTP-induced increases but reduced surface AMPAR levels prior to cLTP is again consistent with AMPAR recycling occurring through multiple endocytosis pathways, one pathway providing AMPARs inserted during cLTP and the other pathway primarily involved in constitutive AMPAR recycling.

In neurons expressing TC10 mutants during cLTD, we observed only half the cLTD-induced decrease in AMPARs with TC10DN, while TC10CA did not alter the cLTD-induced decrease ([Figure 4A,B](#fig4){ref-type="fig"}). These results are different from what occurs during LTP and suggest that the TC10- and Arf6-dependent endocytosis pathway is involved to some degree in the AMPAR trafficking during LTD that removes AMPARs from synapses. To more directly test how TC10DN and TC10CA affect the trafficking of synaptic AMPARs during LTD, we induced LTD by low-frequency synaptic stimulation ([@bib34]; [@bib35]) ([Figure 4C](#fig4){ref-type="fig"}). Similar to what we observed with cLTD, the AMPAR-mediated synaptic currents were reduced by 52.4% ± 0.5% by LTD. During LTD, AMPAR EPSCs were reduced by 27.5% ± 1.0% in the presence of TC10DN, and TC10CA had no effect on LTD (a 48.3% ± 1.0% reduction) ([Figure 4C](#fig4){ref-type="fig"}). We could not perform similar experiments with LTP because LTP cannot be induced by electrical stimulation in dissociated cultures ([@bib48]; [@bib28]). However in a previous study, we found that the same cLTP protocol applied to dissociated hippocampal neuronal cultures caused a LTP of EPSC amplitudes ([@bib28]).

Our results with TC10DN or TC10CA expression on AMPAR trafficking during cLTP suggest that constitutive and activity-dependent AMPAR recycling occurs through different pathways. To further test this possibility, we assayed how cLTP altered the levels of internalized GluA1 subunit co-localization with TfRs or with Arf6-HA. We observed that 21% ± 2% of the internalized AMPARs co-localized with TfR ([Figure 4D,E](#fig4){ref-type="fig"}), consistent with a previous estimate of the amount of internalized AMPARs that co-localized with TfR during constitutive recycling ([@bib39]). 52% of the internalized AMPAR co-localized with Arf6-HA and 27% of internalized AMPARs did not co-localize with TfRs or with Arf6-HA ([Figure 4E](#fig4){ref-type="fig"}). This pool of internalized AMPARs is likely in a different endosomal pool such as early endosomes, late endosomes, or lysosomes ([@bib16]). After cLTP induction, the distribution of internalized AMPARs in the different pools changed: cLTP increased the amount of internalized GluA1 that co-localized with TfR from 21% to 56% ([Figure 4E](#fig4){ref-type="fig"}; [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}), while the internalized GluA1 that co-localized with Arf6 was unchanged (52% vs 47%; [Figure 4E](#fig4){ref-type="fig"}; [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). cLTP increased the total amount of internalized GluA1 by 24% ± 5% ([Figure 4D](#fig4){ref-type="fig"}), while the pool of internalized AMPARs that did not co-localize with TfRs or with Arf6-HA was no longer measurable. Our results are consistent with significant changes in AMPAR endocytosis and recycling that occurs during cLTP. During constitutive recycling, AMPARs appear to be recycling primarily through a dynamin-independent, Arf6-, and TC10-dependent pathway though some recycle through a dynamin-dependent, TfR-containing pathway. After cLTP, a much larger fraction of the AMPARs recycle through the dynamin-dependent pathway taken by TfRs. Our results further suggest that after LTP, fewer AMPARs are trafficked for degradation via a late endosomal/lysosomal pathway as previously described ([@bib16]).

Discussion {#s3}
==========

Constitutive AMPAR recycling and TC10 {#s3-1}
-------------------------------------

The findings of this study are consistent with constitutive AMPAR recycling occurring largely through a pathway different from the clathrin-dependent pathway used by TfRs. The data in support of an alternative recycling pathway are that internalized AMPARs co-localize much more with Arf6 than with TfRs ([Figure 2](#fig2){ref-type="fig"}), and that inhibition of dynamin function blocks TfR endocytosis without significantly altering AMPAR endocytosis ([Figure 3](#fig3){ref-type="fig"}). The features of the alternative AMPAR recycling pathway, for example, presence of Arf6 and independence from dynamin function, are consistent with a clathrin-independent endocytosis pathway ([@bib12]; [@bib13]). The Arf6-mediated, clathrin-independent pathway is a separate endocytosis pathway that exists in neurons and mediates the endocytosis and recycling of a number of different receptors and transport proteins. These include the metabotropic glutamate receptors (mGluR), mGluR5 ([@bib17]) and mGluR7 ([@bib26]), and the potassium channel Kir3.4 ([@bib20]). AMPARs were shown to undergo a clathrin-independent recycling pathway, in addition to clathrin-mediated pathway in *Caenorhabditis elegans* ([@bib19]). Another study using electron microscopy (EM) ([@bib49]) also suggests that constitutive AMPAR recycling occurs through a different pathway. The study found that all intracellular structures with the features of REs were labeled for TfRs in dendritic shafts of cultured rat hippocampal neurons but only 28% of these REs were labeled for AMPARs. If AMPAR endocytosis occurs through a single, clathrin-dependent pathway, AMPARs would all enter clathrin-coated pits during constitutive AMPAR recycling. Entry into clathrin-coated pits can only be unambiguously resolved at the EM level. EM studies assaying AMPAR subunit localization in clathrin-coated pits observed few AMPARs in clathrin-coated pits ([@bib42]; [@bib49]). Tao-Cheng et al. found that 76% of the clathrin-coated pits contained TfRs but only 24% of the pits contained AMPAR subunits. Clathrin-coated pits near PSDs have been proposed to be specialized endocytic zones (EZs) ([@bib5]; [@bib44]) that mediate endocytosis of AMPA receptors for local recycling in spines ([@bib30]; [@bib43]; [@bib25]). Both EM studies failed to detect any AMPAR labeling in the EZs at synapses under conditions where constitutive AMPAR recycling was occurring ([@bib42]; [@bib49]).

In this study, we have also characterized in detail the role of the small Rho GTPase, TC10, in AMPAR recycling through the Arf6-mediated, clathrin-independent pathway. We found that altering TC10 expression and function in neurons reduced levels of cell-surface AMPARs. The TC10 mutants, TCDN and TC10CA, equally reduced cell-surface AMPARs by ∼50% but did not significantly affect AMPAR trafficking through the secretory pathway. Normal levels of AMPARs departed from the somatic Golgi and were transported to dendrites and synapses. However, the TC10 mutants had differential effects on where AMPARs accumulated in dendritic shafts. TC10DN reduced surface AMPARs by causing increased AMPAR accumulation in Arf6 endosomes apparently by blocking their exit from the endosomes. TC10CA reduced surface AMPARs by increasing their exit from Arf6 endosomes and blocking their exocytosis, thereby increasing what appear to be AMPAR transport vesicles in the dendritic shafts.

Results from a previous study suggest that the associations between TC10 and AMPARs are indirect, requiring an adaptor protein, nPIST, which interacts with the AMPAR TARP subunit ([@bib11]). nPIST, like TC10, primarily co-localizes with Golgi markers in the somata of cultured hippocampal neurons. But it is also found in puncta in dendritic shafts, not in spines, and the puncta do not co-localize with Golgi membranes ([@bib8]). nPIST interactions with TC10 in dendrites, thus, are likely at the Arf6 endosomes where we observed most of TC10 in dendrites. One possibility is that TC10 acts to regulate interactions between nPIST and AMPAR TARP subunits when present together in Arf6 endosomes, and thereby, regulate the trafficking of AMPARs from Arf6 endosomes to dendritic exocytosis sites.

Activity-dependent AMPAR recycling {#s3-2}
----------------------------------

Our findings that AMPARs recycle through two different pathways provide new insights into how AMPAR recycling is altered in response to changes in synaptic activity. The increase in AMPARs in REs after cLTP reflects a redistribution of trafficking AMPARs in dendrites such that AMPAR receptor recycling via REs is increased, while recycling via the Arf6-TC10-containing endosomes was unchanged. We also observed a third pool of endocytosed AMPARs that did not co-localize with either TfR or Arf6. This third pool, which should include AMPARs in early endosomes, late endosomes and lysosomes, decreased from 27% of the total to essentially 0%. A previous study suggested that during LTD an activity-dependent switch occurs such that more endocytosed AMPARs in early endosomes were routed to the Rab7-dependent pathway to lysosomes and less were routed to the recycling endosome pathway ([@bib16]). Our data suggest that the opposite is occurring during cLTP. That is, an activity-dependent switch occurs such that few to none of the endocytosed AMPARs in early endosomes are routed via the Rab7-dependent pathway to lysosomes. Instead, virtually all AMPARs in early endosomes are routed to the REs. However, this switch can only explain part of the increase in AMPARs in REs during cLTP because the total number of endocytosed AMPARs increased by an additional 24%. Thus, part of the increase in AMPARs in REs during cLTP appears to be caused by an increase in AMPAR endocytosis, presumably at clathrin-coated pits

Expression of TC10DN increased AMPARs in Arf6-containing endosomes, while TC10CA decreased AMPARs in these endosomes ([Figure 2C,D](#fig2){ref-type="fig"}). The differential effects of TC10DN and TC10CA on AMPAR localization in Arf6-containing endosomes provide a potential explanation for the differential effects of TC10DN and TC10CA during LTD. It is possible that AMPARs excluded from Arf6-containing endosomes by TC10CA have access to the endosomal pathway used during LTD. The AMPARs added to the Arf6-containing endosomes with TC10DN expression do not have access to the endosomal pathway used during LTD.

Previous studies have found that synaptic stimulation increases dynamin- and clathrin-dependent AMPAR endocytosis ([@bib7]; [@bib31]; [@bib14]; [@bib27]; [@bib46]; [@bib49]). In some of these studies, blocking dynamin/clathrin-dependent endocytosis prevented LTD but did not alter constitutive AMPAR endocytosis. It was also found that blocking constitutive AMPAR endocytosis by interfering with NSF binding to GluA2 subunits does not alter LTD or activity-dependent AMPAR endocytosis ([@bib7]; [@bib31]; [@bib14]; [@bib27]). Altogether, these studies demonstrate that activity-dependent and constitutive AMPAR recycling can be uncoupled, and thus, appears to be independently regulated, consistent with separate processes underlying activity-dependent and constitutive AMPAR recycling. Our results with TC10 mutants are also consistent with separate processes underlying activity-dependent and constitutive AMPAR recycling.

Why are there different AMPAR endocytosis pathways? {#s3-3}
---------------------------------------------------

The results from this study suggest that the two different AMPAR recycling pathways serve different functions. The Arf6-dependent recycling pathway, also dependent on TC10 function, predominates during AMPAR constitutive recycling. Another recycling pathway, which is dynamin and clathrin dependent, increases during AMPAR activity-dependent recycling (cLTP and cLTD). The simplest model of AMPAR recycling based on our data is displayed in [Figure 5B](#fig5){ref-type="fig"}. To explain the effects of dynamin inhibition, we propose that the two recycling pathways originate at separate endocytosis sites, either clathrin-coated pits or clathrin-independent sites. As proposed by others ([@bib13]) but not shown in the model, the two recycling pathways merge at early endosomes, where AMPARs would be sorted for trafficking into the various pools, either the REs used by TfRs, the Arf6-depedent REs or late endosomes for lysosomal degradation. As proposed in the model, the two recycling pathways end when AMPARs are exocytosed at separate sites at the cell membrane. The presence of two different AMPAR recycling exocytosis sites may help to explain recent data describing different AMPAR recycling exocytosis sites ([@bib25]; [@bib1]). We envision that the Arf6/TC10-dependent recycling pathway has largely a caretaker role, delivering AMPARs to early endosomes where a decision is made to degrade internalized AMPARs or return them to the plasma membrane. The dynamin/clathrin-dependent recycling functions predominantly during synaptic activation and appear to have a different role than the Arf6/TC10-depedent recycling pathway ([Figure 5](#fig5){ref-type="fig"}). Other receptors are regulated in a similar way by the same two recycling pathways. β2-adrenergic and M3 muscarinic receptors undergo constitutive recycling when not activated by ligand via an Arf6-dependent, clathrin-independent pathway. After ligand activation, their recycling pathway switches and recycling occurs via the clathrin-dependent pathway ([@bib45]). The recycling pathway of α1-integrin receptors also switches after their activation ([@bib3]).10.7554/eLife.06878.015Figure 5.New model for AMPAR constitutive and activity-dependent recycling.(**A**) Conventional 'single-synapse' AMPAR recycling model. AMPARs exit post-synaptic densities (PSDs) by lateral diffusion and are endocytosed into clathrin-coated pits at sites near PSDs. After, endocytosed AMPARs are sorted into recycling endosomes (REs), the same pathway used by TfR for recycling back to the cell surface, where AMPARs diffuse to and could be trapped in PSDs. An underlying assumption of the model is that AMPAR recycling is restricted to single spines and the endosomal membranes in the spine and dendrite neighboring the spine. Activity during LTP increases AMPAR exocytosis and transport from REs without altering its endocytosis thereby decreasing AMPAR levels in REs. (**B**) AMPAR recycling model with two AMPAR-recycling pathways under constitutive conditions. Based on evidence in this study, at least two different AMPAR-recycling pathways exist for AMPAR recycling. AMPARs largely recycle through the Arf6- and TC10-dependent recycling pathway, which originates at sites near the PSD and endocytose at clathrin- and dynamin-independent sites. This recycling pathway acts to move AMPARs from sites near the PSD to sites distant from the synapse such that AMPARs cannot return via membrane diffusion. Smaller numbers of AMPARs endocytose at sites distant from the spine via clathrin-coated pits using dynamin. Endocytosed AMPARs traffic into REs in the same pathway as TfRs. This recycling pathway acts to move AMPARs from distant sites to sites accessible to PSDs so that AMPARs can diffuse into PSDs to balance the loss via the Arf6-dependent recycling pathway. (**C**) AMPAR recycling after cLTP. Activity-dependent events during cLTP increase AMPAR recycling through the dynamin-dependent pathway, trafficking AMPARs from clathrin-coated pits distant from the stimulated synapse to sites accessible to the stimulated PSD. Endocytosed AMPARs are transported in the REs with the net effect of trafficking more AMPARs into the stimulated PSD. AMPAR recycling through the Arf6- and TC10-dependent recycling pathway continues unchanged after cLTP. (**D**) AMPAR recycling after cLTD. Similar to what is observed after cLTP, activity-dependent events during cLTP increase AMPAR recycling through the dynamin-dependent pathway except with the net effect of trafficking AMPARs out of PSDs and away from the stimulated spines. AMPAR endocytosis occurs at clathrin-coated pits near stimulated PSD and AMPARs transported in REs away from the cLTD spines and recycling to the cell surface at distant sites. The Arf6- and TC10-dependent recycling pathway, shown in (**B**), is also unchanged during cLTD, and overall traffic AMPARs out of synaptic spines.**DOI:** [http://dx.doi.org/10.7554/eLife.06878.015](10.7554/eLife.06878.015)

Our finding that AMPAR recycling through the dynamin/clathrin-dependent pathway increased during cLTP provides insights into the function of this pathway during AMPAR recycling. Previously, it was assumed that AMPAR recycling was largely confined to a single synaptic spine and the dendrite area nearby ([Figure 5A](#fig5){ref-type="fig"}). Increases in synaptic AMPARs during NMDAR-dependent LTP were thought to increase AMPAR exocytosis without increasing AMPAR endocytosis causing a decrease in the level of AMPARs in REs ([@bib32]; [@bib6]; [@bib9]; [@bib39]; [@bib47]). However, we found that AMPAR levels in REs increased after LTP, and endocytosis increased in parallel with increased AMPAR levels at synapses during cLTP. Our results suggest that AMPAR recycling is not limited to trafficking AMPARs into and out of the same synaptic spine. Instead, we suggest that AMPAR recycling has the additional function of transporting AMPARs to sites distant from where they originate. Increased AMPAR endocytosis during cLTP occurs through the dynamin-dependent recycling pathway starting at clathrin-coated pits at sites distant from synapses undergoing cLTP ([Figure 5C](#fig5){ref-type="fig"}). Consistent with this idea, AMPARs were not found in clathrin-coated pits at spines but in clathrin-coated pits well outside spines along the dendritic shafts ([@bib49]). After endocytosis, we propose that AMPARs are trafficked in REs outside the synaptic spine region ([Figure 5C](#fig5){ref-type="fig"}). Consistent with this trafficking role are studies demonstrating that different kinds of endosomes, including REs, travel long distances to new locations during recycling in dendrites and axons ([@bib51]). Furthermore, an EM study using three-dimensional reconstruction analysis found that in dendrites of rat, hippocampal neurons independent REs were not maintained at each spine. Instead, up to 20 spines shared a single recycling endosome ([@bib10]). In our model ([Figure 5C](#fig5){ref-type="fig"}), AMPAR exocytosis sites for the dynamin/clathrin-dependent pathway during cLTP are placed within the spine to deliver the AMPARs within the diffusible pool near the PSD of the synapse. In short, we propose that the role for the dynamin/clathrin-dependent recycling pathway during cLTP is to move AMPARs from sites distant from synaptic activation to sites near the activated synapse.

During cLTD, we propose that AMPAR recycling via the dynamin/clathrin-dependent recycling pathway is also increased similar to what occurs during cLTP. Recycling AMPARs in TfR-containing REs are trafficked in and out of synapses and along dendrites except in the opposite direction ([Figure 5D](#fig5){ref-type="fig"}). This is consistent with many studies that have found that AMPAR endocytosis increases via the dynamin/clathrin-dependent pathway. However, it has been assumed that during LTD, increased AMPAR endocytosis occurs without increased AMPAR exocytosis resulting in larger local endosomal stores of AMPARs. Instead, we suggest that during cLTD, AMPARs are transported away from synapses. In support of this idea, [@bib49] reported the appearance of AMPARs in clathrin-coated pits within synaptic spines, which was not observed during constitutive conditions or cLTP. This finding suggests that AMPARs near synapses are only removed locally via clathrin-coated pits during cLTD. In our model, AMPARs are trafficked during cLTD from clathrin-coated pits at activated spines via REs to distant sites. Overall, AMPARs flow out of synaptic spines during cLTD and into synaptic spines during cLTP. The function of the dynamin/clathrin-dependent recycling pathway is, thus, to traffic AMPARs from regions of low activity to regions of high activity and in this way the pathway underlies a Hebbian redistribution of AMPARs.

Our finding that TC10WT expression had opposite effects on synaptic AMPAR currents, a measure of functional synaptic AMPARs, and the cell-surface levels of dendritic AMPARs suggests that the Arf6/TC10-dependent recycling pathway traffics AMPARs out of synaptic spines. In this study, we conclude that TC10 regulates AMPAR recycling through the Arf6/TC10-dependent pathway. The simplest explanation for why TC10WT expression acts to increase cell-surface AMPARs levels is that it increases exocytosis from Arf6-dependent pathway REs so that fewer AMPARs are in the Arf6 endosomes and more AMPARs are in the plasma membrane. The decrease in the levels of synaptic AMPARs with TC10WT expression can be explained if the Arf6-dependent recycling pathway acts to traffic AMPARs via endocytosis and exocytosis from synapses to distant plasma membrane sites. For this reason, in our model, we have placed the endocytosis site of the Arf6-dependent recycling pathway near the PSD and the exocytosis site outside of the spine ([Figure 5B](#fig5){ref-type="fig"}). During constitutive AMPAR recycling, if AMPAR recycling via the Arf6-dependent recycling pathway acts to move synaptic AMPARs out of the spine and away from the synapse, then counteracting processes must be bringing other AMPARs back to the synapse in order to keep the levels of AMPAR constant. During cLTD ([Figure 5D](#fig5){ref-type="fig"}), we suggest that the Arf6/TC10-dependent recycling pathway acts together with the dynamin/clathrin-dependent pathway to traffic AMPARs away from synaptic spines. If the Arf6/TC10-dependent recycling pathway traffics AMPARs out of the spines then blocking it would act to reduce LTD, as we observed with TC10DN expression ([Figure 4A--C](#fig4){ref-type="fig"}). As explained above, the differential effects of TC10DN and TC10CA during LTD may arise from the differences in how they act during the Arf6/TC10-dependent recycling pathway. During constitutive conditions ([Figure 5B](#fig5){ref-type="fig"}) and during cLTP ([Figure 5C](#fig5){ref-type="fig"}), the Arf6/TC10-dependent recycling pathway would act counter to the dynamin/clathrin-dependent pathway, which in our model would traffic AMPARs into synaptic spines under these conditions. This aspect of our model explains why blocking Arf6/TC10-dependent recycling pathway with the TC10DN expression may actually increase levels of LTP ([Figure 4A--C](#fig4){ref-type="fig"}).

Materials and methods {#s4}
=====================

Antibodies {#s4-1}
----------

The following primary antibodies were used: anti-RFP (MBL, rabbit, \#PM005), anti-GM130 (BD Biosciences, mouse, 1:500), anti-transferrin receptor (Zymed, Thermo Scientific Pierce, Waltham, MA, \#13-6800, 1:300), anti-synapsin (Chemicon, EMD Millipore, Temecula, CA, mouse, 1:500), anti-Bassoon (Synaptic Systems, Goettingen, Germany, Guinea Pig, 1:300), anti-GFP (Sigma-Aldrich, St. Louis, MO, rabbit, 1:5000), anti-GluR1 (Millipore, EMD Millipore, Billerica, mouse; CalBioChem, Merck Millipore, Temecula, CA, rabbit). Dynasore was from Sigma (D7693); Sulfo-NHS-SS-biotin was from Pierce.

cDNA cloning and mutagenesis {#s4-2}
----------------------------

Human TC10 constructs were obtained from Dr. J. Marshall (Brown University), and then subcloned into the pSP2 vector, containing a CMV promoter and Venus tag (a brighter and more photostable YFP variant) to generate fusion proteins. mCherry-GluA1 construct was obtained from Dr. C. Garner (Stanford University). Rat TC10, Cdc42, and Rab11 genes were cloned from mRNA of 20 DIV cortical neuron cultures by RT-PCR with the following primers: TC10: FWD (with EcoRI) 5′-CCTTACATAGAATTCATGGCTCACGGGCCC-3′, REV (with BamHI) 5′-GGCCCAGTGGATCCTCACGTAATCAAACAACAGTTTATAC-3′; Cdc42: FWD (with EcoRI) 5′-CGTTACTAAGAATTCATGGGCACCCGCGAC-3′, REV (with BamHI) 5′-GGCCTCGACGGATCCTTAGATGTTCTGACAGCACTGC-3′; Rab11: FWD (with EcoRI) 5′-CGTTACTAAGAATTCATGGGCACCCGCGAC-3′, REV (with BamHI) 5′-GGCCTCGACGGATCCTAAGATGTTCTGACAGCACTGC-3′. The genes were then inserted into a customized vector (originated from pEYFP from Clontech, Takara, Mountain View, CA) with a CMV promoter and mCherry tag. The lentiviral vector, FUGW, and the helper plasmids, Δ8.9 and VSVg, were obtained from Dr. C. Garner (Stanford University) and were used to clone all genes listed above for production of lentiviruses. The 3 candidate RNAi constructs for TC10 were purchased from Sigma--Aldrich.

Primary neuronal culture and transfections {#s4-3}
------------------------------------------

Rat E18 hippocampal neurons were cultured on poly-L-lysine treated coverslips in Neurobasal medium supplemented with NS21 and GlutaMAX. At 14--17 DIV, neurons were transfected by Lipofectamine 2000 with serum-free Neurobasal medium. The amount of cDNA transfected ranges from 1 to 2 μg per coverslip (d = 12 mm) as needed. Hippocampal cultures were prepared using Neurobasal medium, 2% (vol/vol) B27, and GlutaMAX. Briefly, hippocampi from embryonic (E18--19) Sprague Dawley rats of either sex were dissected, dissociated in 0.05% trypsin (vol/vol, Life Technologies, Thermo Fisher Scientific, Grand Island, NY), and cells were plated at a density of ∼4 × 10^5^ cells/mL on poly-L-lysine-coated 12-mm coverslips. Coverslips were maintained in Neurobasal medium containing B27 and GlutaMAX (all from Life Technologies).

Neuronal cultures were transfected at 14--17 DIV with the Lipofectamine 2000 transfection reagent (Life Technologies) according to manufacturer\'s recommendations, with the exception that 1--2.5 μg of each cDNA in 62.5 μl of Neurobasal media and 2.0 μl of Lipofectamine 2000 in 62.5 μl of Neurobasal media were mixed and added to coverslips in 12-well plates.

Production of lentiviruses and infection of neurons {#s4-4}
---------------------------------------------------

Freshly thawed HEK cells were cultured in DMEM + 10% fetal bovine serum (FBS) medium. Lentiviral plasmid and the helper plasmids were transfected using Ca~3~(PO~4~)~2~ method. ∼50 hr after transfection, supernatant containing the virus particles was collected. After a brief centrifugation to remove cell debris, the virus solution was then mixed with PEG 8000 to incubate at 4°C overnight, followed by centrifugation at 4000 rpm for 30 min at 4°C. The virus pellect was then resuspended in cold phosphate buffered saline (PBS). At 0--1 DIV, neurons were infected with high-titer lentiviruses, and 2 days post-infection, culture medium was changed with fresh Neurobasal, B27, and GlutaMAX.

Immunofluorescence staining and microscope imaging {#s4-5}
--------------------------------------------------

For surface labeling, primary antibody was added into the culture medium and incubated at room temperature for 30 min, or for 20 min at 37°C. Cells were then washed with PBS and fixed with 4% PFA/4% sucrose/PBS for 10 min, then incubated with blocking solution (2% glycine, 1% BSA, 0.2% gelatin, 0.5M NH~4~Cl, PBS) for 1 hr and secondary antibody in blocking solution at room temperature for 1 hr. For internalized staining (antibody-feeding assay), primary antibody was added into the culture medium and incubated at 37°C for 40 min, then cells were washed with acid wash buffer (0.5M NaCl, 0.5% acetic acid, pH2) for 30 s, and fixed. Cells were then incubated with blocking solution and secondary antibody. For permeabilized staining, after fixation, the cells were permeablized in 0.1% Triton/PBS for 5--10 min, blocked and stained with primary and secondary antibodies. The stained coverslips were mounted to glass slides with ProLong Gold (Life Technologies) mounting media and left in dark to harden overnight.

For internalized staining of Tf-Alexa 647, Tf-Alexa 647 was added into the culture medium and incubated at 37°C for 1 hr. Then, cells were washed with acid wash buffer and fixed for imaging.

All images were taken on either an Olympus DSU or Marianas Yokogawa type spinning disk confocal microscope with back-thinned EMCCD camera. Z-stack slices were taken with 0.2-μm step size, with 5--10 slices for each cell. For the surface staining experiments, *z*-plane limits for acquisition were determined by the surface staining on dendrites; for the assay to measure changes in Golgi/endosomal/synaptic localization of GluA1, the *z*-plane limits were set according to organelle marker staining (GM130, transferrin receptor or Arf6, and synapsin, respectively).

cLTP and cLTD protocols {#s4-6}
-----------------------

To induce chemical LTP, DIV17 neurons were washed in Mg^2+^ free buffer (in mM: NaCl 150, CaCl~2~ 2, KCl 5, HEPES 10, glucose 30, strychnine 0.001, bicuculline 0.02) 3 times, and incubated in glycine buffer (Mg^2+^ free buffer with 0.2 mM glycine) at 37°C for 15 min. Then, Mg^2+^ buffer (Mg^2+^ free buffer with 2 mM MgCl~2~) was added to block NMDARs and cells were incubated at 37°C for 30 min before live surface labeling with anti-RFP.

To induce chemical LTD, 14 DIV neurons were washed in Mg^2+^ free buffer 3 times, and incubated in NMDA buffer (Mg^2+^ free buffer with 0.02 mM NMDA) at 37°C for 5 min. Then, Mg^2+^ buffer was added and cells were incubated at 37°C for 1 hr before live surface labeling.

Quantification of images and statistical tests {#s4-7}
----------------------------------------------

Image quantification was performed using NIH ImageJ software. To calculate the surface/total ratio for exogenously expressed GluA1, all images of the same channel were first background subtracted using the same averaged value, which was measured manually across images (with variation \<0.5%). The sum of pixel intensity for the z-stack was calculated using the 'sum of slices' and 'histogram' functions, excluding zero-intensity pixels. The surface/total ratio was then calculated as the ratio of the intensity of surface channel to total channel.

Surface expression of endogenous GluA1 was quantified using 'sum of slice' *z*-projections of images. Each field was background subtracted, and mean intensities were normalized to YFP control.

To measure the Golgi localization of GluA1, the images were background subtracted with the same method described above, and then, the GM130 channel image was thresholded and transformed into a binary mask used to measure the pixel intensity of GluA1 in each slice of the stack. The average intensity of the processed z-stack image was then measured by selecting the cell of interest manually (if more than one cell was present in the image) and applying the 'measure' function.

To measure the degree of co-localization of GluA1 with TfR-positive endosomes, images were assigned a random number and analyzed blindly. Analysis of the co-localization of endogenous GluA1 with TfR was carried out by background subtracting and thresholding image fields so that only puncta that were twofold greater than background were selected. Co-localizing puncta were evaluated using the Analyze Particles function in ImageJ.

To measure the degree of overlap between endogenous GluA1 and Arf6 sub-compartments, we compared fluorescence signals above background in both channels along manually outlined segments of dendrites. Pearson\'s correlation coefficients were generated for background-subtracted image pairs using the Intensity Correlation Analysis plugin in ImageJ. A similar approach was used to measure the degree of overlap between TC10 and Arf6. Thresholded GluA1 punctal size and density in dendritic shafts was analyzed using the Analyze Particle function in ImageJ.

Statistical comparisons were made using two-tailed Student\'s *t* tests or ANOVA/Tukey *post hoc* analysis as indicated. Statistical graphs were generated with Graphpad Prism or StatPlus software.

Whole-cell recording {#s4-8}
--------------------

Dual whole-cell recordings were performed at DIV12--15 on primary dissociated hippocampal cultures transfected with Venus-TC10DN or Venus-TC10CA. Neurons were bathed in carbogen (95% O~2~, 5% CO~2~) bubbled ACSF (in mM: 120 NaCl, 3 KCl, 2 CaCl~2~, 1.25 NaH~2~PO~4~, 2 MgSO~4~, 20 D-(+)-glucose, 26 NaHCO~3~). The internal solution consisted of (in mM): 120 K gluconate or Cs gluconate, 40 HEPES, 5 MgCl~2~, 2 NaATP, 0.3 NaGTP). Recordings were performed at room temperature (21°C). Hippocampal cultures were mounted on an Olympus microscope (BX51WI) and visualized using differential interference microscopy. Transfected neurons were visualized via excitation at 530--550 nm. Electrode resistance was between 5 and 10 MΩ. Patch-clamp recordings were obtained using a MultiClamp 700B Commander (Molecular Devices, Sunnyvale, CA). Data acquisition and analysis were performed using AxoGraph X (AxoGraph Scientific, Sydney, Australia) and pCLAMP 9 (Molecular Devices) software. Events were sampled at 10 kHz and low-pass filtered at 2 kHz. Series resistance (Rs) was monitored throughout all experiments, and results were not included if significant variation (\>20%) occurred during any experiment. Action potentials were induced in presynaptic neurons by a 20-ms current injection of 20--100 pA. AMPAR EPSCs in response to presynaptic action potentials were collected at 0.1 or 0.2 Hz. Statistical significance of changes in AMPAR EPSC amplitudes was tested using Student\'s t test with a level of significance set at p \< 0.05.

Biotinylation and isolation of the internalized pool {#s4-9}
----------------------------------------------------

Cortical neurons were pretreated with 80 μM dynasore or 1% DMSO for 40 min at 37°C. Cells were then washed, and incubated with 0.5 mg/mL Sulfo-NHS-SS-Biotin at 4°C for 30 min, and excessive Sulfo-NHS-SS-Biotin was washed off. Cells were then incubated at 37°C for 1 hr in the presence of 80 μM dynasore or 1% DMSO. Then Sulfo-NHS-SS-Biotin on the cell surface was cleaved with glutathione. Cells were then harvested and lysed; biotinylated proteins were pull down using streptavidin--sepharose beads and were analyzed on Western blot.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "Synaptic Activity Regulates AMPA Receptor Trafficking Through Different Recycling Pathways" for consideration at *eLife*. Your article has been favorably evaluated by Vivek Malhotra (Senior editor), a Reviewing editor, and two reviewers.

The Reviewing editor in consultation with other reviewers has assembled the following comments to help you prepare a revised submission.

1\) All the figures with micrographs are very small on the page and hard to visualize. This may be partially technical (figure quality) and thus the figures need improvement.

2\) The ability of TC10 to alter constitutive AMPAR trafficking, the lack of overlap of the constitutive AMPAR pathway and the transferrin pathway and the selective effect of dynasore on the transferrin pathway appear to be convincing. However, it gets a little muddy when TC10 and LTP do not overlap, but TC10 partially overlaps LTD. This needs an explanation.

3\) Moreover, the experimental evidence for these two pathways is primarily based on overexpressed and tagged proteins. Although not an absolute requirement, the authors should at least try to show that endogenous GluA1 obeys the trafficking rules with TC10 and its mutants that they report for exogenous GluA1.

4\) According to the model, one would expect a greater proportion of AMPARs colocalizing with the TC10/Arf6 machinery before LTP; LTP induction should shift this towards the clathrin pathway. The authors therefore need to show AMPAR distribution prior to and post LTP induction using antibody staining for the two endocytic pathways, if possible. There are good ABs for the clathrin pathway (which have been used in the literature), the Arf6/TC10 ABs are. They are available from Abcam, for example.

5\) It should be demonstrated that the chemLTP protocol indeed works, i.e. potentiates EPSC amplitude and that endogenous AMPARs shift after successful LTP induction from TC10/Arf6 to clathrin.

\[Editors\' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The previous decision letter after peer review is shown below.\]

Thank you for choosing to send your work entitled "Synaptic Activity Regulates AMPA Receptor Trafficking Through Different Recycling Pathways" for consideration at *eLife*. Your full submission has been evaluated by Vivek Malhotra (Senior editor) and four peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the decision was reached after discussions between the reviewers. We regret to inform you that your work will not be considered further for publication.

Although there was some difference in the reviewers\' assessment of the relevance of your study, they agreed that the problem addressed is definitively of interest. However, the experimental work that is required in the reviewers\' opinion is too extensive to allow for a revision according to *eLife* policy. As you can see from the comments below, the reviewers found several sets of data inconsistent with the conclusions. Furthermore, most of them agree that the conclusions go beyond what is supported by the data, and technical issues were also raised. Please note, however, that this feedback is not meant to discourage you from pursuing this line of research further, and they would be interested in looking at the work again if the experiments are further developed.

*Reviewer \#1*:

1\) An essential part of the study uses colocalization (at the LM level) of GFP-tagged and overexpressed AMPA-receptors with organelle markers, most prominently with Arf6 and transferrin-receptor, as read-out for identifying the subcellular localization. However, the way colocalization is analyzed is highly problematic. This is exemplified in [Figure 3C](#fig3){ref-type="fig"}: Here Arf6 yields a granular but rather diffuse staining whereas GluA1 is punctate. Considering the diffuse staining of Arf6, a high degree of colocalization would be scored anywhere along the dendrite. Obviously, this problem is owing to the limited resolution (as no super-resolution techniques were employed). At least, the authors should analyze the images by cross-correlation analysis using line-scans along the dendrite. Another (although related) method may be to move all Glu-A1 spots by 500 nm along the central axis of the dendrite and then re-evaluate colocalization. This degree of colocalization can then be used as correction factor (random vs. specific colocalization). Considering the images provided, I am not at all convinced that GluA1 and Arf6 indeed reside on the same organelle, at least not to the high degree claimed in the manuscript. By the way, what is the value of colocalization if the analysis is done inversely (percentage of Arf colocalizing with GluA1)?

This problem affects all colocalization analysis and thus constitutes a serious problem of the study. For Arf6 and TC10 the colocalization appears to be more conspicuous but again this needs to be quantified by cross-correlation analysis (using line-scans).

2\) Overexpression of multi-subunit and multi-spanning membrane proteins in any cell type is problematic since the folding and trafficking pathways are easily overloaded. Indeed, the pattern of mCherry-GluA1 gives rise to concerns: The accumulation in what appears to be the ER hints towards a "jam" in trafficking that may be related to folding problems or to an overload of the trafficking system. Under such overload conditions, proteins are known to "spill-over" towards other organelles, and they may cause changes in the ratio between surface and endogenous pools. As control, stainings should be carried out for the endogenous receptor (both using untransfected neurons and neurons transfected with the reporter construct) to ensure that there is no perturbation of trafficking due to the overexpression.

3\) Another problem (at least in my view) is that in the stainings synapses cannot be unequivocally identified (which could be done e.g. by colocalization with synaptic markers). Thus, the conclusions suggesting that the two recycling pathways differ in their subcellular localization (clathrin-dependent and activity-dependent: synaptic, constitutive: extrasynaptic) is not directly proven.

4\) The authors state that dynasore treatment does not affect GluA1 endocytosis, in contrast to the endocytosis of transferrin. These data appear to be convincing. However, when comparing sham and dynasore treated neurites in [Figure 4A](#fig4){ref-type="fig"} dynasore appears to cause substantial change in the GluA1 staining pattern (much more diffuse). What is the reason for this? Does the Arf6-staining pattern (which, according to the authors, should label the same compartment) change in a comparable manner?

*Reviewer \#2*:

First, they show that knock-down of TC10 reduces surface expression of exogenous mCherry-GluA1. Similarly, expressing dominant negative DN and const. active CA TC10 reduces surface GluA1. The authors should offer an explanation as to why both mutants have produced the same phenotype. Also, in addition to monitoring fluorescent exogenous GluA1 it would be worth determining whether the effect of TC10 KO and TC10 mutant-expression holds for endogenous AMPARs as one would expect (using a surface biotinylation protocol, for example).

The result of the paired recordings is somewhat puzzling. If, as they suggest, TC10 indeed differentiates between surface vs synaptic AMPAR it would be worth considering to determine AMPAR levels in somatic patches (which are expected to be elevated in response to TC10 WT expression).

*Reviewer \#3*:

There are two sorts of data in this paper. One is the effect of a TC10 mutant on the level of GluA1 in a cell compartment or on the extent of a process, such as cLTP. Specifically, the authors express wild type TC10 (WT) and dominant negative (DN) and constitutively active (CA) TC10 mutants and carry out knockdown (KD) of TC10 to dissect GluA1 trafficking. It is confusing that DN and CA expression and KD can have the same effects, decreasing dendritic GluA1 surface levels, while WT has the opposite effect, increasing dendritic GluA1 surface levels (Results section and [Figure 1](#fig1){ref-type="fig"}). Why should enhancing and blocking TC10 function have the same result? The authors state that because the DN and CA mutants reduced surface expression to the same extent, the AMPARs lost from the Arf6 endosomes must be redistributed to an unidentified intracellular compartment. Isn\'t it possible that overexpression interferes with trafficking non-specifically?

The other is the effect of a mutant on the colocalization of GluA1 with a marker, in particular with transferrin endocytosed by the transferrin receptor. This latter form of data seems more compelling to me and on the basis of such data they authors argue that TC10 functions in GluA1 trafficking associated with Arf6 rather than with the transferrrin receptor, which is a marker for clathrin/dynamin mediate recycling/secretory pathway. The authors conclude that two pathways operate.

Making a case for the operation for the two pathways is important. And for the most part, the data seem respectable. However, the logic for interpretations of the data often escape me, as is the case with similar effects of DN, CA expression and KD of TC10. Also, the authors completely neglect a vast amount of literature that states that GluA1 trafficking is controlled by phosphorylation of the C-terminal domain of the subunit. The authors suggest that TC10 functions in controlling the interaction of nPIST with TARPS that are in complexes with AMPA receptors. But there is abundant evidence that GluA1 phosphorylation, such as takes place during LTP, regulates GluA1 trafficking to and from the surface. The literature does not distinguish which pathway is affected by this phosphorylation (clathrin dependent versus independent), and in this sense the paper contributes a new view. Yet it does so while overlooking the fact that phosphorylation controls the trafficking, be it TC10-dependent or independent.

*Reviewer \#4*:

[Figure 1](#fig1){ref-type="fig"}. Pictures of neurons only show soma ([Figure 1A](#fig1){ref-type="fig"}) and it would be useful to show the entire neuron, at least in the first figure. Notably, this is all overexpression data and the reader would be enlightened if they also examined endogenous AMPA-R levels. (They do look at endogenous GluA1 later on in terms of localization with known recycling markers). Another concern: discrepancy between electrophysiology and surface labeling of AMPA-Rs for TC10WT vs mutants.

[Figure 2](#fig2){ref-type="fig"}. Based on title of this figure, the actual supporting data are limited. For instance denditric shaft primary data are only shown for TC10DN and not other conditions, but phenomenon of dendritic accumulation is generalized to all. This is also the only positive data in the figure (other panels are negative) so the authors should be more thorough. The GM130 colocalization data take up most of figure, and doesn\'t add a lot. Overall it isn\'t a very thorough investigation of potential effects on forward trafficking.

[Figure 3](#fig3){ref-type="fig"} and [Figure 4](#fig4){ref-type="fig"}. One concern: DN and CA have different effects on colocalization yet have same effects on AMPA-R accumulation in dendrites?

Also, the biochemistry in [Figure 4D](#fig4){ref-type="fig"} is poorly controlled. The authors should show total protein amounts and also negative control (intracellular protein).

[Figure 5](#fig5){ref-type="fig"}. The TC 10DN mutant seems to affect LTD, but not LTP- however the authors follow up on LTP showing that it involves dynamin dependent pathways, while neglecting to follow up on the LTD results. The LTD effect I mostly ignored when summarizing their results overall. Also, it is essential for the authors to include representative images along with any quantifications.

Figure 6. It is nice to have a model figure, but this one is too far reaching. A simpler model included in another figure might be more appropriate.

10.7554/eLife.06878.017

Author response

*1) All the figures with micrographs are very small on the page and hard to visualize. This may be partially technical (figure quality) and thus the figures need improvement*.

We have improved all of the figures as requested in the new submission.

2\) The ability of TC10 to alter constitutive AMPAR trafficking, the lack of overlap of the constitutive AMPAR pathway and the transferrin pathway and the selective effect of dynasore on the transferrin pathway appear to be convincing. However, it gets a little muddy when TC10 and LTP do not overlap, but TC10 partially overlaps LTD. This needs an explanation.

We have provided a more detailed explanation in the Discussion section.

3\) Moreover, the experimental evidence for these two pathways is primarily based on overexpressed and tagged proteins. Although not an absolute requirement, the authors should at least try to show that endogenous GluA1 obeys the trafficking rules with TC10 and its mutants that they report for exogenous GluA1.

We performed the experiment requested by the reviewer in the previous resubmission (see new [Figures 1C and F](#fig1){ref-type="fig"}). Because our primary interest was the recycling of AMPARs on dendrites, we tested the effects of TC10WT, TC10DN and TC10CA on the endogenous AMPARs on dendrites using an antibody that recognizes an extracellular epitope on GluA1. We obtained results basically identical to the results obtained with the transfected Cherry-GluA1 (compare [Figures 1E and F](#fig1){ref-type="fig"}).

4\) According to the model, one would expect a greater proportion of AMPARs colocalizing with the TC10/Arf6 machinery before LTP; LTP induction should shift this towards the clathrin pathway. The authors therefore need to show AMPAR distribution prior to and post LTP induction using antibody staining for the two endocytic pathways, if possible. There are good ABs for the clathrin pathway (which have been used in the literature), the Arf6/TC10 ABs are. They are available from Abcam, for example.

In [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}, we display images of neurons after cLTP or sham-treated. The neurons are stained for internalized mCherry-GluR1 and either native transferrin receptors or for Arf6-HA.

We have attempted, without success, to stain the neurons with several Arf6/TC10 antibodies. We have discussed our lack of results with Dr. Julie Donaldson (NIH), who is an expert in this area. She also has had significant difficulty staining neurons with Arf6/TC10 antibodies.

5\) It should be demonstrated that the chemLTP protocol indeed works, i.e. potentiates EPSC amplitude and that endogenous AMPARs shift after successful LTP induction from TC10/Arf6 to clathrin.

This experiment has already been performed by Dr. Jo Montgomery, who is the electrophysiologist on the manuscript. In a previous paper (Li D, Specht CG, Waites CL, Butler-Munro C, Leal-Ortiz S, Foote JW, Genoux D, Garner CC, Montgomery JM (2011) SAP97 directs NMDA receptor spine targeting and synaptic plasticity. J Physiol 589:4491-- 4510) in [Figure 1A](#fig1){ref-type="fig"}, Dr. Montgomery showed using the same chemLTP protocol as in our manuscript, and a similar hippocampal neuronal culture preparation, that the chemLTP protocol works with respect to potentiating EPSC amplitude long-term. We have added a sentence to the manuscript pointing this out (please see the subsection headed "Changes in synaptic activity alter the recycling pathway taken by AMPARs").

\[Editors' note: the author responses to the previous round of peer review follow.\]

The manuscript had previously been rejected with the provision that you "would be interested in looking at the work again if the experiments are further developed". We believe that the experiments have been further developed with several new experiments and significant new analysis of the data performed and added to the manuscript. We feel that these additions address all of the reviewers\' concerns, and also provide added insights into the details of how TC10 acts to regulate the recycling of AMPA receptors at synapses, a major concern of the reviewers.

We also feel that there is some misunderstanding of the significance of our findings. How AMPA receptors are recycled at synapses is an important issue in neuroscience because it is one of the main mechanisms by which long-lasting synaptic changes occur with changes in activity. The consensus in the field is that AMPA receptor recycling occurs through the following single pathway (see [Figure 4A](#fig4){ref-type="fig"}). First, endocytosis occurs through the clathrin-dependent pathway taken by transferrin receptors. Second, the endocytosed AMPA receptors, like transferrin receptors, remain in recycling endosomes prior to their exocytosis. Third, exocytosis from recycling endosomes returns AMPA receptors to the same synapse from which endocytosis occurs. This model predicts that increases in AMPA receptors at synapses occur by increased exocytosis from recycling endosomes. Decreases in AMPA receptors at synapses occur by increased AMPA receptor endocytosis from the synapse. The model is so well accepted that a number of labs use fluorescently tagged transferrin receptors, which are much more abundant at synapses than AMPA receptors, as a substitute for AMPA receptors in their trafficking studies. Based on our results, transferrin receptor trafficking is quite different from that of AMPA receptors.

We believe that the results reported in our manuscript are significant because they challenge this conventional model of AMPAR recycling and provide new information about how AMPA receptors recycle at synapses. We have significant evidence that AMPARs recycle through at least two different pathways. One pathway is routed through endosomes lacking transferrin receptors but containing Arf6 and TC10. This pathway predominates without synaptic activity paradigms that cause long-term potentiation (LTP) and long-term depression (LTD). Also, trafficking via this pathway is reduced by the TC10 mutants with the GDP-bound mutation, which causes AMPA receptors to pile up in the endosomes, and the GTP-bound mutation, which causes AMPA receptors to exit the endosomes but pile up in transport vesicles prior to fusion with the plasma membrane. LTP and LTD do not appear to affect recycling through this pathway but do affect recycling through the second pathway, which is the same recycling pathway taken by transferrin receptors. Contrary to the currently accepted model, increased AMPAR levels caused by LTP caused large increases in AMPA receptor endocytosis. These data indicate that the second recycling pathway is regulated by synaptic activity. It also suggests that AMPA receptors are trafficked into the synapse via the second recycling pathway from regions outside the synapse.

Reviewer \#1:

*1) An essential part of the study uses colocalization (at the LM level) of GFP-tagged and overexpressed AMPA-receptors with organelle markers, most prominently with Arf6 and transferrin-receptor, as read-out for identifying the subcellular localization. However, the way colocalization is analyzed is highly problematic. This is exemplified in* [*Figure 3C*](#fig3){ref-type="fig"}: *Here Arf6 yields a granular but rather diffuse staining whereas GluA1 is punctate. Considering the diffuse staining of Arf6, a high degree of colocalization would be scored anywhere along the dendrite. Obviously, this problem is owing to the limited resolution (as no super-resolution techniques were employed). At least, the authors should analyze the images by cross-correlation analysis using line-scans along the dendrite.*

This degree of colocalization can then be used as correction factor (random vs. specific colocalization). Considering the images provided, I am not at all convinced that GluA1 and Arf6 indeed reside on the same organelle, at least not to the high degree claimed in the manuscript. By the way, what is the value of colocalization if the analysis is done inversely (percentage of Arf colocalizing with GluA1)?

This problem affects all colocalization analysis and thus constitutes a serious problem of the study. For Arf6 and TC10 the colocalization appears to be more conspicuous but again this needs to be quantified by cross-correlation analysis (using line-scans).

To address the reviewer\'s concerns we repeated the experiments (in former [Figure 3C](#fig3){ref-type="fig"}, now new [Figure 2C](#fig2){ref-type="fig"}) and were able to obtain significantly better resolution of the Arf6 immunofluorescence, as well as performing the analysis along the lines suggested by the reviewer. The Arf6 fluorescence was better resolved using a spinning disk confocal outfitted with a 100x Alpha Plan-Fluar/NA 1.45 objective. Instead of the diffuse staining, Arf6 in the new images is clearly found in an intracellular sub-compartment in dendrites from which co-localization with other proteins was better measured. The TC10 and GluA1 fluorescence signals were also better resolved. For GluA1, the improved resolution revealed clear differences in the size and number of GluA1 puncta, as now analyzed in new [Figure 2](#fig2){ref-type="fig"}.

As suggested by the reviewer, we re-analyzed the data in the figure using cross-correlation analysis in order to better assess co-localization of GluA1 with Arf6 and different TC10 constructs. The figures relevant to this concern are all in a separate rebuttal figure (see below). We measured the extent of overlap between channels using a specially developed algorithm that yields Pearson\'s correlation coefficients for dendrites in each image pair. This was achieved by comparing fluorescence signal above background in both channels, along manually outlined segments of dendrites. This is a standard method for evaluating the correlation of pixel intensity distributions between channels ([Author response image 1A](#fig6){ref-type="fig"}). We also performed a second, independent method of analysis to assess the degree to which GluA1 is enriched in Arf6-positive endosomes ([Author response image 1B](#fig6){ref-type="fig"}). We thresholded and masked dendritic Arf6 signal then measured GluA1 pixel intensities in these structures. Using this method, we measured a significant loss in GluA1 signal in Arf6 endosomes following TC10CA expression, also reflected by the loss of spatial overlap indicated by the decrease in Pearson\'s correlation coefficient. Both methods agreed that there were sizable increases and decreases in the distribution of GluA1 in Arf6 endosomes following expression of TC10DN and TC10CA mutants, respectively ([Figure 2C](#fig2){ref-type="fig"}). Cross-correlation analysis demonstrated that these were statistically significant changes ([Figure 2D](#fig2){ref-type="fig"}, [Author response image 1A](#fig6){ref-type="fig"}).10.7554/eLife.06878.018Author response image 1.Improved co-localization analysis. A. Quantification of the overlap between GluA1 and Arf6. Newly acquired images (examples in [Figure 2C](#fig2){ref-type="fig"}) were analyzed to measure the Pearson\'s correlation coefficients (R~r~) of GluA1 co-localization with Arf6. Data are shown as mean ± SEM; TC10WT 0.46 ± 0.04; TC10DN 0.66 ± 0.04; TC10CA 0.31 ± 0.04 (n= 7-10 cells per group; \*p\<0.02 relative to TC10WT; \*\*p\<0.05 relative to TC10WT). B. A second method of analysis. GluA1 pixel intensity was measured in thresholded and masked Arf6 sub-compartments. Data are shown as mean ± SEM (normalized to TC10WT); TC10WT 1.0 ± 0.11; TC10DN 1.3 ± 0.10; TC10CA 0.56 ± 0.09 (n= 8-10 cells per group; \*\*p\<0.03 relative to TC10WT. C, Representative image of Arf6-HA and GluA1 in the dendritic shaft of a TC10DN expressing neuron (left panels), and with the GluA1 channel shifted along the central axis of the dendrite by ∼500nm (right panels). Bottom panels display line scans of pixel intensities for both channels along the yellow line in the dendrite. D, Change in Pearson\'s correlation coefficients following lateral shift of GluA1 channel in (C). Data are shown as mean ± SEM; TC10DN 0.66 ± 0.04; TC10DN shifted pixels 0.37 ± 0.05 (n=7 cells per group; \*p\<0.002).**DOI:** [http://dx.doi.org/10.7554/eLife.06878.018](10.7554/eLife.06878.018)

Another (although related) method may be to move all Glu-A1 spots by 500 nm along the central axis of the dendrite and then re-evaluate colocalization.

We performed the analysis requested by the reviewer, shown in detail in [Author response image 1C](#fig6){ref-type="fig"}. We used the method suggested by the reviewer to determine the specificity of any measured co-localization. Expression of TC10DN yielded the highest co-localization between GluA1 and Arf6 (R~r~ = 0.7; [Figure 2D](#fig2){ref-type="fig"}). We shifted the GluA1 channel along the central axis of dendrites by ∼500 nm and re-evaluated co-localization. Line scan analysis ([Author response image 1C](#fig6){ref-type="fig"}; bottom panels) illustrated an expected shift and mismatch in intensity peaks for the two channels along dendrites, and a corresponding and significant decrease in the Pearson\'s correlation coefficient (R~r~ = 0.37; [Author response image 1D](#fig6){ref-type="fig"}). These findings also support the significance of our methods used to measure specific co-localization in these dendritic sub-compartments.

2\) Overexpression of multi-subunit and multi-spanning membrane proteins in any cell type is problematic since the folding and trafficking pathways are easily overloaded. Indeed, the pattern of mCherry-GluA1 gives rise to concerns: The accumulation in what appears to be the ER hints towards a "jam" in trafficking that may be related to folding problems or to an overload of the trafficking system. Under such overload conditions, proteins are known to "spill-over" towards other organelles, and they may cause changes in the ratio between surface and endogenous pools. As control, stainings should be carried out for the endogenous receptor (both using untransfected neurons and neurons transfected with the reporter construct) to ensure that there is no perturbation of trafficking due to the overexpression.

We performed the experiment requested by the reviewer. In [Figure 1---figure supplement 4B](#fig1s4){ref-type="fig"}, representative images of somata are shown comparing staining for endogenous GluA1 subunits with that for the transfected Cherrry-GluA1. For both sets of neurons, the ER was simultaneously stained with an antibody against the ER marker, PDI. In both sets of neurons, the ER looks normal and GluA1 subunits are clearly largely found in the ER membrane. No evidence of a "jam" in trafficking was observed.

3\) Another problem (at least in my view) is that in the stainings synapses cannot be unequivocally identified (which could be done e.g. by colocalization with synaptic markers). Thus, the conclusions suggesting that the two recycling pathways differ in their subcellular localization (clathrin-dependent and activity-dependent: synaptic, constitutive: extrasynaptic) is not directly proven.

This concern appears to be a misunderstanding of our proposed model of AMPAR recycling. We did not propose that the two recycling pathways differ in their subcellular localization (clathrin-dependent and activity-dependent: synaptic, constitutive: extrasynaptic). There were no experiments where we use staining to distinguish synaptic vs extrasynaptic locations, and we completely agree with the reviewer that the staining methods used in this manuscript are inappropriate to distinguish synaptic vs. extrasynaptic locations. What may have confused the reviewer is that we distinguished synaptic from total surface AMPARs ([Figure 1](#fig1){ref-type="fig"}) by comparing synaptic currents with cell-surface staining. Attempts have been made to make these points clearer in the manuscript.

4\) The authors state that dynasore treatment does not affect GluA1 endocytosis, in contrast to the endocytosis of transferrin. These data appear to be convincing. However, when comparing sham and dynasore treated neurites in [*Figure 4A*](#fig4){ref-type="fig"} dynasore appears to cause substantial change in the GluA1 staining pattern (much more diffuse). What is the reason for this? Does the Arf6-staining pattern (which, according to the authors, should label the same compartment) change in a comparable manner?

We apologize for the image previously displayed in old [Figure 4A](#fig4){ref-type="fig"} (now new [Figure 3A](#fig3){ref-type="fig"}) for the dynasore-treated neurons. We have repeated the experiments and carefully compared the GluA1 staining for sham and dynasore treated neurons using a spinning disk confocal outfitted with a 100x Alpha Plan-Fluar/NA 1.45 objective. We do not find significant differences between the two conditions as the previous image may have suggested. The previous image appears to have been somewhat out of focus. In the representative images in new [Figure 3A](#fig3){ref-type="fig"}, dynasore treatment appears to have no effect on the distribution of GluA1, but TfR distribution appears to be altered, consistent with the dynasore-induced reduction in its internalization as shown in [Figure 3B](#fig3){ref-type="fig"} and [Figure 3C](#fig3){ref-type="fig"}.

Reviewer \#2:

First, they show that knock-down of TC10 reduces surface expression of exogenous mCherry-GluA1. Similarly, expressing dominant negative DN and const. active CA TC10 reduces surface GluA1. The authors should offer an explanation as to why both mutants have produced the same phenotype.

This is an excellent question that was also a concern of Reviewers 3 and 4. To partially address this concern, we have rewritten the Results section where we now describe the data of others who have studied the role of TC10 in the secretory pathway. In two papers they found that TC10DN and TC10CA reduced secretion in the range of 40-60% ([@bib24]), similar to our findings with AMPARs ([Figure 1](#fig1){ref-type="fig"}). Using a TC10 FRET sensor construct to assay whether TC10 is in the GTP-TC10 or GDP-TC10 state, they concluded that the TC10 GTPase hydrolysis cycle is required for NPY secretion. TC10DN and TC10CA both reduced secretion by blocking the GTP hydrolysis cycle at different steps. Similar results were obtained using a different secretion assay in PC12 cells ([@bib18]). Both papers suggested that during exocytosis TC10CA allowed cargo to load into transport vesicles to be delivered to target membranes. TC10CA blocked exocytosis by preventing the GTP-TC10 to GDP-TC10 transition required for transport vesicle docking and/or fusion. In contrast, the results suggest that TC10DN blocked the GDP-TC10 to GTP-TC10 transition, which blocked a different step, cargo loading onto vesicles, thus preventing vesicle delivery to target membranes.

The other way we have addressed this concern was by analyzing in more detail how TC10DN and TC10CA affect the distribution of AMPARs in dendrites (new [Figures 2C--F](#fig2){ref-type="fig"}) and comparing the findings to previous studies that have characterized how TC10DN and TC10CA affect the trafficking of other proteins. In new data added to the manuscript, we found that when TC10DN increases the co-localization between GluA1 and Arf6, the GluA1 AMPARs appear to co-localize within a subdomain of the Arf6 fluorescence, consistent with TC10DN blocking AMPAR exit from the Arf6 endosomes. We also found that when TC10CA decreases the co-localization between GluA1 and Arf6 there is an increase in the number of smaller AMPAR puncta (new [Figure 2E](#fig2){ref-type="fig"}) consistent with an increased number of AMPAR transport vesicles that are not exocytosed.

Also, in addition to monitoring fluorescent exogenous GluA1 it would be worth determining whether the effect of TC10 KO and TC10 mutant-expression holds for endogenous AMPARs as one would expect (using a surface biotinylation protocol, for example).

We performed the experiment requested by the reviewer (new [Figures 1C and F](#fig1){ref-type="fig"}). Because our primary interest was the recycling of AMPARs on dendrites, we tested the effects of TC10WT, TC10DN and TC10CA on the endogenous AMPARs on dendrites using an antibody that recognizes an extracellular epitope on GluA1. We obtained results basically identical to the results obtained with the transfected Cherry-GluA1 (compare [Figures 1E and F](#fig1){ref-type="fig"}).

The result of the paired recordings is somewhat puzzling. If, as they suggest, TC10 indeed differentiates between surface vs synaptic AMPAR it would be worth considering to determine AMPAR levels in somatic patches (which are expected to be elevated in response to TC10 WT expression).

It is not clear what the reviewer is asking for here. In [Figures 1A and D](#fig1){ref-type="fig"}, we have measured the fluorescence of surface AMPARs at the somata and find that TC10WT appeared to have increased GluA1 surface levels but the increase was not statistically significant. It might be possible with somatic outside-out patches to assay to some degree AMPAR levels electrophysiologically with the application of agonist to the patches. In considering it, we felt that this experiment is unlikely to yield significant results because of the difficulties involved with performing it, the possibility that some synaptic receptors may be included in the somatic patches and that we were unable to obtain a significant result using fluorescent methods.

Reviewer \#3:

*There are two sorts of data in this paper. One is the effect of a TC10 mutant on the level of GluA1 in a cell compartment or on the extent of a process, such as cLTP. Specifically, the authors express wild type TC10 (WT) and dominant negative (DN) and constitutively active (CA) TC10 mutants and carry out knockdown (KD) of TC10 to dissect GluA1 trafficking. It is confusing that DN and CA expression and KD can have the same effects, decreasing dendritic GluA1 surface levels, while WT has the opposite effect, increasing dendritic GluA1 surface levels (Results section and* [*Figure 1*](#fig1){ref-type="fig"}). *Why should enhancing and blocking TC10 function have the same result?*

This concern was the same as Reviewer 2\'s point 1 and addressed above.

The authors state that because the DN and CA mutants reduced surface expression to the same extent, the AMPARs lost from the Arf6 endosomes must be redistributed to an unidentified intracellular compartment. Isn\'t it possible that overexpression interferes with trafficking non-specifically?

The other is the effect of a mutant on the colocalization of GluA1 with a marker, in particular with transferrin endocytosed by the transferrin receptor. This latter form of data seems more compelling to me and on the basis of such data they authors argue that TC10 functions in GluA1 trafficking associated with Arf6 rather than with the transferrrin receptor, which is a marker for clathrin/dynamin mediate recycling/secretory pathway. The authors conclude that two pathways operate.

Making a case for the operation for the two pathways is important. And for the most part, the data seem respectable. However, the logic for interpretations of the data often escape me, as is the case with similar effects of DN, CA expression and KD of TC10. Also, the authors completely neglect a vast amount of literature that states that GluA1 trafficking is controlled by phosphorylation of the C-terminal domain of the subunit. The authors suggest that TC10 functions in controlling the interaction of nPIST with TARPS that are in complexes with AMPA receptors. But there is abundant evidence that GluA1 phosphorylation, such as takes place during LTP, regulates GluA1 trafficking to and from the surface. The literature does not distinguish which pathway is affected by this phosphorylation (clathrin dependent versus independent), and in this sense the paper contributes a new view. Yet it does so while overlooking the fact that phosphorylation controls the trafficking, be it TC10-dependent or independent.

We completely agree with the reviewer that GluA1 phosphorylation of the C-terminal domain plays an important regulatory role in its recycling and it is very likely to regulate the different events described in this manuscript. We could begin to address this question by altering different kinases and phosphatases, mutating different potential phosphorylation sites on GluA1 or using antibodies specific for the phosphorylated GluA1 protein. Similarly we could address the role of other AMPAR subunit posttranslational modifications such palmitoylation and ubiquitination that have been found to regulate AMPAR recycling. These experiments would definitely begin to characterize in more detail the regulatory mechanisms of the two recycling pathways we describe here and we are very interested in performing them in the future. However, it is not clear to us how these experiments or a discussion of the relevant literature would help answer the basic questions addressed in this manuscript.

Reviewer \#4:

[*Figure 1*](#fig1){ref-type="fig"}. *Pictures of neurons only show soma (*[*Figure 1A*](#fig1){ref-type="fig"}*) and it would be useful to show the entire neuron, at least in the first figure. Notably, this is all overexpression data and the reader would be enlightened if they also examined endogenous AMPA-R levels. (They do look at endogenous GluA1 later on in terms of localization with known recycling markers). Another concern: discrepancy between electrophysiology and surface labeling of AMPA-Rs for TC10WT vs mutants.*

We agree completely and have added new images that show most of the whole neurons for each of the somas that were displayed in [Figure 1A](#fig1){ref-type="fig"} as requested. However, much of the detail described in the Results section is lost because of the reduced sizes of the somata. For this reason and to keep [Figure 1](#fig1){ref-type="fig"} a reasonable size, we have added these images as [Figure 1---figure supplement 4A](#fig1s4){ref-type="fig"}.

[*Figure 2*](#fig2){ref-type="fig"}. *Based on title of this figure, the actual supporting data are limited. For instance denditric shaft primary data are only shown for TC10DN and not other conditions, but phenomenon of dendritic accumulation is generalized to all. This is also the only positive data in the figure (other panels are negative) so the authors should be more thorough. The GM130 colocalization data take up most of figure, and doesn\'t add a lot. Overall it isn\'t a very thorough investigation of potential effects on forward trafficking.*

Again, we agree completely and removed all of the data from the figures and now display them as [Figure 1---figure supplement 4C--E](#fig1s4){ref-type="fig"}.

[*Figure 3*](#fig3){ref-type="fig"} *and* [*Figure 4*](#fig4){ref-type="fig"}. *One concern: DN and CA have different effects on colocalization yet have same effects on AMPA-R accumulation in dendrites?*

This concern was the same as Reviewer 2\'s point 1 and addressed above.

*Also, the biochemistry in* [*Figure 4D*](#fig4){ref-type="fig"} *is poorly controlled. The authors should show total protein amounts and also negative control (intracellular protein).*

Both the total protein amounts (inputs) and a negative control using the intracellular protein actin have been added to the figure (new [Figure 3D](#fig3){ref-type="fig"}) as requested.

[*Figure 5*](#fig5){ref-type="fig"}. *The TC 10DN mutant seems to affect LTD, but not LTP- however the authors follow up on LTP showing that it involves dynamin dependent pathways, while neglecting to follow up on the LTD results. The LTD effect I mostly ignored when summarizing their results overall.*

The reason that we did not perform the same antibody-loading experiments on cLTD as were performed on cLTP is that many previous studies have already found that AMPAR endocytosis is increased during LTP and that it involves the dynamin-dependent pathway. However, the experiments had not been performed on cLTP.

Also, it is essential for the authors to include representative images along with any quantifications.

We agree with the reviewer and have added the representative images to the manuscript as requested. They were not included previously because the images are very similar to those in new [Figure 3A](#fig3){ref-type="fig"}. Also, old [Figure 5](#fig5){ref-type="fig"} (new [Figure 4](#fig4){ref-type="fig"}) is already very large and complicated. For these two reasons we have included the representative images as supplements for Figure 6.

Figure 6. It is nice to have a model figure, but this one is too far reaching. A simpler model included in another figure might be more appropriate.

We agree with the reviewer that a simpler model would be better and have tried to come up with one. To explain all of the data presented in the manuscript the model needs to include: 1) the two recycling pathways, 2) how TC10 WT expression could increase AMPAR surface expression while decreasing AMPAR synaptic levels, 3) a lack of effect of TC10 mutants on LTP and LTD, and 4) how AMPAR endocytosis could increase during both LTP and LTD. We felt that the old model in panel A was needed to contrast with the new model in panel B. We also felt that panels C and D were needed to explain the changes that occur with LTP (panel C) and LTD (panel D). At this point, new [Figure 5](#fig5){ref-type="fig"} is the simplest model that we could come up with that explains all of our results and those of others such as [@bib49].
